ciprofloxacin has been researched along with Typhoid Fever in 226 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Typhoid Fever: An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed a randomized controlled trial involving 55 adult patients with enteric fever to compare ciprofloxacin and chloramphenicol." | 9.10 | Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever. ( Djokomoeljanto, R; Dolmans, WM; Gasem, MH; Keuter, M; Van Der Meer, JW; Van Der Ven-Jongekrijg, J, 2003) |
| "To compare clinical and bacteriological efficacies of azithromycin and ciprofloxacin for typhoid fever, 123 adults with fever and signs of uncomplicated typhoid fever were entered into a randomized trial." | 9.09 | Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. ( Brown, FM; Butler, T; Frenck, RW; Girgis, NI; Khakhria, R; Sultan, Y; Tribble, D, 1999) |
| "The efficacy of two regimens of ciprofloxacin was compared in a randomized study conducted on 69 patients with enteric fever, 52." | 9.08 | Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella. ( Alam, MN; Baral, PK; Das, KK; Dutta, P; Haq, SA; Hasan, Z; Khan, MA; Mazid, MN; Rahman, KM; Siddique, RU, 1995) |
| "A randomized trial comparing ceftriaxone (3 g given parenterally per day for 7 days) to ciprofloxacin (500 mg given orally twice a day for 7 days) in the treatment of blood culture positive typhoid fever was conducted." | 9.07 | Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever. ( Hyams, KC; Mahroos, GA; Mapes, T; Rowe, B; Threlfall, EJ; Wallace, MR; Yousif, AA, 1993) |
| "A prospective, open and non-randomised clinical trial using a 7-day short course of oral ciprofloxacin 500 mg twice daily was conducted on 25 adult patients with bacteraemic enteric fever." | 9.07 | A 7-day course of ciprofloxacin for enteric fever. ( Allen, DM; Chew, SK; Lim, YS; Monteiro, EH, 1992) |
| "Sixty-two patients with blood culture-proven typhoid fever were randomly assigned to receive either 500 or 750 mg of ciprofloxacin orally, twice daily for 7 days or for two days following defervescence, whichever was greater." | 9.07 | Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever. ( al Soub, H; Matar, I; Uwaydah, AK, 1992) |
| "Ciprofloxacin and other related fluorinated 4-quinolones have microbiological and pharmacokinetic properties that suggest they could be useful agents in the management of typhoid fever and bacterial gastroenteritis." | 8.78 | Treatment of typhoid fever and infectious diarrhoea with ciprofloxacin. ( Pithie, AD; Wood, MJ, 1990) |
| "Outbreaks of multidrug-resistant Salmonella enterica serotype Typhi in the Indian subcontinent in the late 1980s resulted in the failure of conventional drugs, and ciprofloxacin became the firstline drug to treat enteric fever." | 7.73 | Ciprofloxacin therapy for typhoid fever needs reconsideration. ( Chitnis, DS; Chitnis, S; Chitnis, V; Hemvani, N, 2006) |
| "We report a case of ciprofloxacin treatment failure in a typhoid fever patient at a tertiary care hospital in Rawalpindi, Pakistan." | 7.72 | Ciprofloxacin treatment failure in typhoid fever case, Pakistan. ( Ahmad, RN; Butt, T; Mahmood, A; Zaidi, S, 2003) |
| "With emerging drug resistance, ciprofloxacin became the frontline antibiotic against Salmonella strains causing enteric fevers worldwide." | 7.72 | Enteric fever caused by Salmonella isolates with decreased susceptibility to ciprofloxacin. ( Atukorala, SD; Karunanayake, L, 2004) |
| "A total of 140 children, aged 3-10 yr, clinically diagnosed as having typhoid fever, without any clinical response after 12-14 days of ciprofloxacin therapy were screened for S." | 7.71 | Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children. ( Bhattacharya, SK; Chatterjee, MK; De, A; Dutta, P; Dutta, S; Mitra, U, 2001) |
| "In recent times there have been several reports of chloramphenicol resistant enteric fever necessitating the use of other antimicrobial agents." | 7.68 | Chloramphenicol resistant enteric fever. ( Chakravorty, B; Gupta, B; Jain, N; Krishna, A; Rajvanshi, P; Sen, MK, 1993) |
| "Eighteen children with bacteriologically confirmed severe typhoid fever were initially treated intravenously with ciprofloxacin (10 mg/kg of body weight per day)." | 7.68 | Ciprofloxacin for treatment of severe typhoid fever in children. ( Bhattacharya, MK; Bhattacharya, SK; Dutta, P; Lahiri, M; Mitra, U; Rasaily, R; Saha, MR, 1993) |
| "A study was conducted to investigate the effects of ciprofloxacin in typhoid fever and to compare its efficacy with chloramphenicol." | 7.68 | Role of ciprofloxacin in typhoid fever. ( Akhtar, MA; Hussain, A; Karamat, KA; Naqi, N; Zubdi, N, 1992) |
| " We used this technique to compare the cost-effectiveness of chloramphenicol and ciprofloxacin in the treatment of enteric fever." | 7.68 | Chloramphenicol and ciprofloxacin in enteric fever--cost-effectiveness. ( Geroge, TP; Narendranathan, M, 1992) |
| "Multi-drug resistant Typhoid fever (resistant to previously used chloramphenicol, ampicillin, amoxicillin, and trimethoprim-sulfamethoxazole) has been commonly described in the South East Asia region and a recent report suggests that the salmonella typhi have reduced response to fluoroquinolones (nalidixic acid-resistant)." | 7.01 | Open Label Randomized Controlled Comparison of Three Alternative Regimes of Ciprofloxacin, Azithromycin and Cefixime for Treatment of Uncomplicated Typhoid Fever in Bangladesh. ( Ahmed, SM; Amin, MR; Das, SK; Hasan, MJ; Islam, MR; Kabir, A, 2021) |
| "Two developed recurrence of paratyphoid fever, 17 days and 4 months after therapy." | 6.67 | Short course ciprofloxacin therapy for enteric fever. ( Jesudason, MV; John, J; Kaur, A; Keystone, JS; Kozarsky, PE; Kudva, GC; Lalitha, MK; Mathai, D; Pulimood, BM; Thomas, M, 1993) |
| " The data was used for the development of a population pharmacokinetic model by using non-linear mixed-effect modeling (NONMEM) software." | 5.62 | Population pharmacokinetics of ciprofloxacin in Pakistani patients suffering from enteric fever. ( Abbas, M; Khan, HM; Khan, RR; Khokhar, MI; Maqsood, Z; Rasheed, H; Saleem, R; Usman, M; Zaman, M, 2021) |
| "The epidemiology of typhoid fever in South Asia has changed." | 5.48 | Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. ( Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B, 2018) |
| "Typhi strains from patients with typhoid fever seen at our center in 1995 (median MIC 0." | 5.32 | Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. ( Abraham, OC; Jesudason, MV; John, TJ; Mathai, D; Rupali, P; Sivaram, S; Zachariah, A, 2004) |
| "He developed non-oliguric acute renal failure that was treated successfully." | 5.28 | Typhoid fever, ciprofloxacin, and renal failure. ( Dodd, K; Mellersh, A; Nelson, CS; Simpson, J; Watson, AR, 1991) |
| "We performed a randomized controlled trial involving 55 adult patients with enteric fever to compare ciprofloxacin and chloramphenicol." | 5.10 | Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever. ( Djokomoeljanto, R; Dolmans, WM; Gasem, MH; Keuter, M; Van Der Meer, JW; Van Der Ven-Jongekrijg, J, 2003) |
| "To compare clinical and bacteriological efficacies of azithromycin and ciprofloxacin for typhoid fever, 123 adults with fever and signs of uncomplicated typhoid fever were entered into a randomized trial." | 5.09 | Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. ( Brown, FM; Butler, T; Frenck, RW; Girgis, NI; Khakhria, R; Sultan, Y; Tribble, D, 1999) |
| "The efficacy of two regimens of ciprofloxacin was compared in a randomized study conducted on 69 patients with enteric fever, 52." | 5.08 | Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella. ( Alam, MN; Baral, PK; Das, KK; Dutta, P; Haq, SA; Hasan, Z; Khan, MA; Mazid, MN; Rahman, KM; Siddique, RU, 1995) |
| "A randomized trial comparing ceftriaxone (3 g given parenterally per day for 7 days) to ciprofloxacin (500 mg given orally twice a day for 7 days) in the treatment of blood culture positive typhoid fever was conducted." | 5.07 | Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever. ( Hyams, KC; Mahroos, GA; Mapes, T; Rowe, B; Threlfall, EJ; Wallace, MR; Yousif, AA, 1993) |
| "A prospective, open and non-randomised clinical trial using a 7-day short course of oral ciprofloxacin 500 mg twice daily was conducted on 25 adult patients with bacteraemic enteric fever." | 5.07 | A 7-day course of ciprofloxacin for enteric fever. ( Allen, DM; Chew, SK; Lim, YS; Monteiro, EH, 1992) |
| "Sixty-two patients with blood culture-proven typhoid fever were randomly assigned to receive either 500 or 750 mg of ciprofloxacin orally, twice daily for 7 days or for two days following defervescence, whichever was greater." | 5.07 | Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever. ( al Soub, H; Matar, I; Uwaydah, AK, 1992) |
| "The introduction of chloramphenicol in 1948 revolutionised the outcome of typhoid fever but chloramphenicol-resistant strains of Salmonella enterica serotype Typhi were reported just two years later." | 4.86 | [Typhoid fever: facing the challenge of resistant strains]. ( Weill, FX, 2010) |
| " Typhi) from a case of enteric fever gave a ciprofloxacin MIC of 64 microg/ml." | 4.84 | A case report and review of the literature: ciprofloxacin resistant Salmonella enterica serovar Typhi in India. ( Harish, BN; Menezes, GA; Parija, SC; Sarangapani, K, 2008) |
| "Ciprofloxacin and other related fluorinated 4-quinolones have microbiological and pharmacokinetic properties that suggest they could be useful agents in the management of typhoid fever and bacterial gastroenteritis." | 4.78 | Treatment of typhoid fever and infectious diarrhoea with ciprofloxacin. ( Pithie, AD; Wood, MJ, 1990) |
| "Enteric fever, Salmonella, Antibiotic sensitivity, Blood culture, MDR, XDR, Azithromycin, Meropenem." | 4.31 | Frequency and Antibiotics Sensitivity Pattern of Culture-Positive Salmonella Typhi in Children. ( Ahmad, M; Shah, N; Siddiqui, MA, 2023) |
| " The higher prevalence of ciprofloxacin nonsusceptibility enforces to limit its use and adhere to the judicious usage of azithromycin and ceftriaxone for enteric fever management." | 4.02 | Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management. ( Abirami, BS; Alexander, AP; Amladi, A; Anandan, S; Bakthavatchalam, YD; Bavdekar, A; De, A; Dutta, S; Evelyn Ebenezer, S; Gupta, M; Jacob, JJ; Jinka, DR; John, J; Kang, G; Kapil, A; Koshy, RM; More, D; Nagaraj, S; Nayakanti, RR; Perumal, SPB; Pragasam, AK; Ray, P; Rongsen-Chandola, T; Saigal, K; Sanghavi, S; Sethuvel, DPM; Shastri, J; Singh, A; Thomas, M; Veeraraghavan, B, 2021) |
| "Total 26 clinical isolates were divided in to two parts: part I included six isolates obtained from three patients with relapse of enteric fever and part II included 20 isolates with different ciprofloxacin MIC levels." | 3.80 | Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure. ( Dahiya, S; Das, BK; Kabra, SK; Kapil, A; Kumar, R; Lodha, R; Sood, S, 2014) |
| "Ciprofloxacin has become the antibiotic of choice for the treatment of typhoid fever with the emergence and worldwide spread of Salmonella enterica typhi strains resistant to chloramphenicol." | 3.75 | Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India. ( Gupta, V; Kaistha, N; Kaur, J, 2009) |
| "As typhoid fever was suspected and finally confirmed, the patient was treated with oral ciprofloxacin for 14 days." | 3.74 | [Acute myocarditis after visiting Pakistan]. ( Kohler, BM; Türoff, A; Vollnberg, H, 2008) |
| "The last two decades have seen a change in the pattern of enteric fever with the emergence of multidrug-resistant strains (MDRS), particularly strains resistant to nalidixic acid." | 3.73 | Current perspectives of enteric fever: a hospital-based study from India. ( Aggarwal, P; Gaind, R; Kalaivani, M; Mehta, R; Paul, P; Walia, M, 2005) |
| "Outbreaks of multidrug-resistant Salmonella enterica serotype Typhi in the Indian subcontinent in the late 1980s resulted in the failure of conventional drugs, and ciprofloxacin became the firstline drug to treat enteric fever." | 3.73 | Ciprofloxacin therapy for typhoid fever needs reconsideration. ( Chitnis, DS; Chitnis, S; Chitnis, V; Hemvani, N, 2006) |
| "We report a case of ciprofloxacin treatment failure in a typhoid fever patient at a tertiary care hospital in Rawalpindi, Pakistan." | 3.72 | Ciprofloxacin treatment failure in typhoid fever case, Pakistan. ( Ahmad, RN; Butt, T; Mahmood, A; Zaidi, S, 2003) |
| "With emerging drug resistance, ciprofloxacin became the frontline antibiotic against Salmonella strains causing enteric fevers worldwide." | 3.72 | Enteric fever caused by Salmonella isolates with decreased susceptibility to ciprofloxacin. ( Atukorala, SD; Karunanayake, L, 2004) |
| "A total of 140 children, aged 3-10 yr, clinically diagnosed as having typhoid fever, without any clinical response after 12-14 days of ciprofloxacin therapy were screened for S." | 3.71 | Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children. ( Bhattacharya, SK; Chatterjee, MK; De, A; Dutta, P; Dutta, S; Mitra, U, 2001) |
| " Ciprofloxacin and dexamethasone were used to treat 11 patients diagnosed on blood culture as having typhoid fever." | 3.70 | Differentiation of typhoid fever from fulminant hepatic failure in patients presenting with jaundice and encephalopathy. ( Chakraborty, A; Jalihal, A; Kamath, PS, 2000) |
| "To provide information about the characteristics of diarrheal stool in multi-drug resistant typhoid fever and observe the clinical course after treatment with furazolidone or ciprofloxacin." | 3.69 | Multi-drug resistant typhoid fever with diarrhea. ( Bhattacharya, SK; Chatterjee, MK; Dutta, P; Garai, T; Manna, B; Mitra, U; Rasaily, R; Saha, MR; Sengupta, M, 1997) |
| "In recent times there have been several reports of chloramphenicol resistant enteric fever necessitating the use of other antimicrobial agents." | 3.68 | Chloramphenicol resistant enteric fever. ( Chakravorty, B; Gupta, B; Jain, N; Krishna, A; Rajvanshi, P; Sen, MK, 1993) |
| "Eighteen children with bacteriologically confirmed severe typhoid fever were initially treated intravenously with ciprofloxacin (10 mg/kg of body weight per day)." | 3.68 | Ciprofloxacin for treatment of severe typhoid fever in children. ( Bhattacharya, MK; Bhattacharya, SK; Dutta, P; Lahiri, M; Mitra, U; Rasaily, R; Saha, MR, 1993) |
| "A study was conducted to investigate the effects of ciprofloxacin in typhoid fever and to compare its efficacy with chloramphenicol." | 3.68 | Role of ciprofloxacin in typhoid fever. ( Akhtar, MA; Hussain, A; Karamat, KA; Naqi, N; Zubdi, N, 1992) |
| " We used this technique to compare the cost-effectiveness of chloramphenicol and ciprofloxacin in the treatment of enteric fever." | 3.68 | Chloramphenicol and ciprofloxacin in enteric fever--cost-effectiveness. ( Geroge, TP; Narendranathan, M, 1992) |
| "Ten patients - two with Salmonella septicaemia associated with AIDS; one each Salmonella excretors in the convalescence stage and with Salmonella osteomyelitis; three with abdominal typhoid, and three with Salmonella enteritis - were treated with the gyrase inhibitor ciprofloxacin." | 3.67 | [Ciprofloxacin in Salmonella infection and abdominal typhoid]. ( Hoffmann, HG; Klein, E; Trautmann, M, 1986) |
| "Extensively drug-resistant (XDR) typhoid has become dominant in Pakistan (70% in 2020) but has not yet become established elsewhere." | 3.01 | Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 ( Aanensen, DM; Afolayan, AO; Alexander, AP; Amir, A; Anandan, S; Andrews, JR; Argimón, S; Ashton, PM; Aworh, MK; Baker, S; Basnyat, B; Bavdekar, A; Bogoch, II; Carey, ME; Chattaway, MA; Chew, KL; Clemens, JD; Crump, JA; da Silva, KE; de Ligt, J; De, A; Diaz Guevara, PL; Dolecek, C; Dougan, G; Dutta, S; Dyson, ZA; Ehlers, MM; Feasey, NA; Francois Watkins, L; Garrett, DO; Godbole, G; Gordon, MA; Greenhill, AR; Griffin, C; Gupta, M; Hendriksen, RS; Heyderman, RS; Holt, KE; Hooda, Y; Hormazabal, JC; Howden, BP; Ikhimiukor, OO; Ingle, DJ; Iqbal, J; Jacob, JJ; Jenkins, C; Jinka, DR; John, J; Kang, G; Kanteh, A; Kapil, A; Kariuki, S; Karkey, A; Keane, JA; Keddy, KH; Kingsley, RA; Koshy, RM; Lauer, AC; Levine, MM; Lingegowda, RK; Luby, SP; Mackenzie, GA; Maes, M; Mashe, T; Msefula, C; Mutreja, A; Nagaraj, G; Nagaraj, S; Nair, S; Naseri, TK; Nimarota-Brown, S; Njamkepo, E; Okeke, IN; Parry, CM; Perumal, SPB; Pollard, AJ; Pragasam, AK; Qadri, F; Qamar, FN; Rahman, SIA; Rambocus, SD; Rasko, DA; Ray, P; Robins-Browne, R; Rongsen-Chandola, T; Rutanga, JP; Saha, S; Saha, SK; Saigal, K; Sajib, MSI; Seidman, JC; Shakya, J; Shamanna, V; Shastri, J; Shrestha, R; Sia, S; Sikorski, MJ; Singh, A; Smith, AM; Tagg, KA; Tamrakar, D; Tanmoy, AM; Thomas, M; Thomas, MS; Thomsen, R; Thomson, NR; Tupua, S; Vaidya, K; Valcanis, M; Van Puyvelde, S; Veeraraghavan, B; Webb, HE; Weill, FX; Wright, J, 2023) |
| "Multi-drug resistant Typhoid fever (resistant to previously used chloramphenicol, ampicillin, amoxicillin, and trimethoprim-sulfamethoxazole) has been commonly described in the South East Asia region and a recent report suggests that the salmonella typhi have reduced response to fluoroquinolones (nalidixic acid-resistant)." | 3.01 | Open Label Randomized Controlled Comparison of Three Alternative Regimes of Ciprofloxacin, Azithromycin and Cefixime for Treatment of Uncomplicated Typhoid Fever in Bangladesh. ( Ahmed, SM; Amin, MR; Das, SK; Hasan, MJ; Islam, MR; Kabir, A, 2021) |
| " In an era of increasing antimicrobial resistance, further studies are required to define appropriate azithromycin dosing regimens for enteric fever and to assess novel treatment strategies, including combination therapies." | 2.90 | Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model. ( Aljayyoussi, G; Angus, B; Ardrey, A; Biagini, GA; Feasey, NA; Gibani, MM; Jin, C; Liu, X; Moore, M; Parry, CM; Pennington, SH; Pollard, AJ, 2019) |
| "Typhoid and paratyphoid (enteric fever) are febrile bacterial illnesses common in many low- and middle-income countries." | 2.82 | Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. ( Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N, 2022) |
| "During a typhoid clinical treatment trial in Nepal, we observed several treatment failures and isolated highly fluoroquinolone-resistant Salmonella Typhi (S." | 2.82 | A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure. ( Arjyal, A; Baker, S; Basnyat, B; Dolecek, C; Dongol, S; Dougan, G; Gajurel, D; Ha Thanh, T; Ho Thi, N; Holt, KE; Karkey, A; Parry, CM; Pham Thanh, D; Pickard, D; Pradhan, A; Rabaa, MA; Shrestha, SK; Thompson, CN; Thwaites, GE; Tran Vu Thieu, N; Voong Vinh, P; Wolbers, M; Wong, V, 2016) |
| "Assessment of paratyphoid vaccine efficacy in preclinical studies is complicated by the lack of a small animal model and the human-restricted nature of the infection." | 2.80 | Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers. ( Angus, B; Campbell, D; Darton, T; Dobinson, HC; Jones, C; Kerridge, S; Martin, LB; McCullagh, D; Plested, E; Pollard, AJ; Snape, M; Stevens, Z; Voysey, M, 2015) |
| "The rarity of acute psychosis in typhoid fever can result in delayed and misdiagnosis of the condition." | 2.72 | Typhoid fever presenting as acute psychosis in a young adult: case report and literature review of typhoid psychosis. ( Ding, CH; Esa, H; Hameed, AA; Norazlah, B; Wahab, AA, 2021) |
| "Two developed recurrence of paratyphoid fever, 17 days and 4 months after therapy." | 2.67 | Short course ciprofloxacin therapy for enteric fever. ( Jesudason, MV; John, J; Kaur, A; Keystone, JS; Kozarsky, PE; Kudva, GC; Lalitha, MK; Mathai, D; Pulimood, BM; Thomas, M, 1993) |
| "Whereas typhoid fever is most prevalent in South and South-East Asia, non-typhoidal salmonellosis is prevalent across the globe and associated with a mild gastroenteritis." | 2.58 | Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing. ( Cuypers, WL; Deborggraeve, S; Jacobs, J; Klemm, EJ; Van Puyvelde, S; Wong, V, 2018) |
| "We discuss diagnostic methods and treatment of enteric fever with special emphasis on typhoid fever." | 2.53 | Typhoid fever: case report and literature review. ( Calzadilla Riveras, J; Farías Molina, S; Hermoso, A; Sanhueza Palma, NC, 2016) |
| "Enteric fever is an increasingly common diagnosis in returning travellers in the UK." | 2.46 | Enteric fever in a UK regional infectious diseases unit: a 10 year retrospective review. ( Clark, TW; Daneshvar, C; Pareek, M; Perera, N; Stephenson, I, 2010) |
| "We describe the first case of typhoid spondylodiscitis in Southeast Asia, and the literature were also reviewed." | 2.46 | Typhoid spondylodiscitis: the first reported case in Southeast Asia and review of the literature. ( Nilgate, S; Suankratay, C; Suwanpimolkul, G, 2010) |
| "We reexamined typhoid fever incidence and antimicrobial resistance (AMR) over a 10-year period in Kibera, a densely populated urban informal settlement where a high burden has been previously described." | 1.91 | Dynamic Incidence of Typhoid Fever over a 10-Year Period (2010-2019) in Kibera, an Urban Informal Settlement in Nairobi, Kenya. ( Agogo, GO; Audi, A; Bigogo, G; Breiman, RF; Fields, BS; Gauld, J; Hunsperger, E; Juma, B; Kiplangat, S; Lind, M; Mikoleit, M; Mintz, ED; Mogeni, OD; Montgomery, JM; Mugoh, R; Munywoki, PK; Ng'eno, E; Ochieng, C; Odongo, G; Oduor, C; Omballa, V; Osita, MP; Ouma, A; Verani, JR; Wamola, N; Widdowson, MA, 2023) |
| "Typhoid fever is caused primarily by the enteric microbe Salmonella enterica serovar Typhi and remains a major global health problem with approximately 14 million new infections and 136,000 fatalities annually." | 1.72 | Identification of a Host-Targeted Compound to Control Typhoid Fever. ( Gunn, JS; Hoang, KV; Melander, C; Woolard, K; Yang, C, 2022) |
| "We retrospectively reviewed typhoid and paratyphoid fever cases in two medical centers of Chang Gung Memorial Hospitals in 2010-2020." | 1.72 | Clinical manifestations and microbiological features between indigenous and imported enteric fever in Taiwan, 2010-2020. ( Chen, CH; Chen, YC; Cheng, SS; Chiu, CH; Hsu, YJ; Kuo, KC, 2022) |
| "Invasive Salmonella infections result in a significant burden of disease including morbidity, mortality, and financial cost in many countries." | 1.72 | Clinical profiles and antimicrobial resistance patterns of invasive Salmonella infections in children in China. ( Chen, M; Gao, H; Jia, C; Li, R; Lin, D; Lin, X; Qiu, Y; Shan, Q; Song, W; Tong, J; Wan, C; Wang, C; Wu, S; Xu, Y; Yang, J; Zeng, M; Zhao, S; Zhu, C; Zhu, Y; Zhuo, Z, 2022) |
| " The data was used for the development of a population pharmacokinetic model by using non-linear mixed-effect modeling (NONMEM) software." | 1.62 | Population pharmacokinetics of ciprofloxacin in Pakistani patients suffering from enteric fever. ( Abbas, M; Khan, HM; Khan, RR; Khokhar, MI; Maqsood, Z; Rasheed, H; Saleem, R; Usman, M; Zaman, M, 2021) |
| "In Korea, typhoid fever is a rare disease due to improved living standards." | 1.62 | Emerging high-level ciprofloxacin-resistant Salmonella enterica serovar typhi haplotype H58 in travelers returning to the Republic of Korea from India. ( Chun, JH; Hwang, KJ; Jeong, HJ; Kim, CJ; Kim, J; Lee, H; Na, K; Park, AK; Park, J; Shin, E, 2021) |
| "Typhoid fever is endemic in most countries, causing major public health problems with high morbidity and mortality, the resistance of Salmonella enterica serovar Typhi (S." | 1.56 | Molecular Detection of ( Habeeb Rasool, K; Hammood Hussein, N; Mahamed Taha, B, 2020) |
| "Typhoid fever is a common infection in Africa and, despite scarce surveillance reports, its incidence is commonly considered high by the Angolan health system." | 1.48 | First report on antimicrobial resistance and molecular characterisation of Salmonella enterica serotype Typhi isolated from human specimens in Luanda, Angola. ( Belas, A; Costa, SS; Couto, I; Francisco, M; Pomba, C; Ramos, J; Viveiros, M, 2018) |
| "The epidemiology of typhoid fever in South Asia has changed." | 1.48 | Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. ( Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B, 2018) |
| "Typhoid fever is a vaccine-preventable bacterial disease that causes significant morbidity and mortality throughout Africa." | 1.48 | Investigation of a typhoid fever epidemic in Moyale Sub-County, Kenya, 2014-2015. ( Abill, K; Boru, WG; Galgallo, DA; Ransom, J; Roka, ZG, 2018) |
| "Typhi) isolated from typhoid fever cases (2004-2007)." | 1.48 | Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya. ( Kariuki, S; Muigai, AWT; Mutai, WC; Waiyaki, P, 2018) |
| "Atotal of 460 typhoidal Salmonellaewere isolated; out of which 270 were Salmonella typhiand 190 were Salmonella paratyphiA." | 1.46 | Current Trends of Antimicrobial Susceptibility of Typhoidal Salmonellae Isolated at Tertiary Care Hospital. ( Hameed, F; Imtiaz, A; Irfan, F; Mirza, IA; Nadeem, S; Zehra, NM, 2017) |
| "Enteric fever has persistence of great impact in Sudanese public health especially during rainy season when the causative agent Salmonella enterica serovar Typhi possesses pan endemic patterns in most regions of Sudan - Khartoum." | 1.46 | Prevalence of current patterns and predictive trends of multidrug-resistant Salmonella Typhi in Sudan. ( Ahmed, AA; El Hussien, AA; El Siddig, MA; Elshayeb, AA, 2017) |
| "Ciprofloxacin resistance was predominantly associated with the triple substitutions Ser83 → Phe and Asp87 → Asn in GyrA and Ser80 → Ile in ParC." | 1.42 | Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002-2013) and molecular characterization of quinolone resistant isolates. ( Abgottspon, H; Cernela, N; Nüesch-Inderbinen, M; Sägesser, G; Stephan, R, 2015) |
| "P." | 1.42 | Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania. ( Butichi, A; Lemnge, M; Lushino, P; Lusingu, J; Mahende, C; Mmbando, B; Ngasala, B; Premji, Z, 2015) |
| "Surveillance data suggest that typhoid has become increasingly common in rural areas of Fiji and is more frequent amongst young adults." | 1.40 | Typhoid fever in Fiji: a reversible plague? ( Acharya, S; Baker, S; Bera, U; Clemens, J; Crump, JA; Dawainavesi, A; Dougan, G; Edmunds, WJ; Fox, K; Jenkins, K; Kama, M; Khan, MI; Koroivueta, J; Levine, MM; Martin, LB; Mulholland, K; Nilles, E; Pitzer, VE; Raiwalu, RV; Singh, S; Thompson, CN, 2014) |
| "Typhoid fever is a major cause of disease burden in developing countries." | 1.39 | First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan. ( Chiu, CH; Huang, YC; Lee, CJ; Su, LH, 2013) |
| "Typhoid fever is a systemic illness which in high-income countries mainly affects travellers." | 1.39 | Cases of typhoid fever in Copenhagen region: a retrospective study of presentation and relapse. ( Barrett, FC; Johansen, IS; Knudsen, JD, 2013) |
| "Typhoid fever is caused by Salmonella enterica serovar Typhi, a major public health concern in developing countries." | 1.38 | Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. ( Goessens, WH; Harish, BN; Hays, JP; Khan, MA; Menezes, GA, 2012) |
| "However the number of septic arthritis cases due to S." | 1.38 | [Septic arthritis of hip due to Salmonella Typhi in a patient with multiple sclerosis]. ( Altay, T; Avcı, M; Coşkuner, SA; Havuk, A; Olut, AI; Ozgenç, O; Ozsu Caymaz, S, 2012) |
| "Typhoid fever is a global health problem caused by Salmonella." | 1.38 | Impact of nitric oxide precursor L-arginine on oxidative stress against typhoid. ( Haque, SS, 2012) |
| "Typhoid fever is a dangerous infection." | 1.37 | [Features of clinic, diagnostics and treatment of typhoid fever in young patients]. ( Karpov, AV; Kondratenok, VA; Kovalenko, AN; Murachev, AA; Shishkin, MK; Tokmakov, VS; Volzhanin, VM; Zhdanov, KV, 2011) |
| "The period of S." | 1.37 | Effect of biofilm formation on the excretion of Salmonella enterica serovar Typhi in feces. ( Ali, A; Haque, A; Jamil, A; Raza, A; Sarwar, Y, 2011) |
| "Typhoid fever is a systemic intracellular infection caused by Salmonellaenterica serotype Typhi." | 1.36 | In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi. ( Jang, SJ; Kim, DM; Kim, SH; Lee, BK; Neupane, GP, 2010) |
| "Thus typhoid fever in Kuwait is predominantly associated with those who have traveled from endemic areas to work in Kuwait." | 1.35 | Salmonella enterica Serotype typhi in Kuwait and its reduced susceptibility to ciprofloxacin. ( Amyes, SG; Dashti, AA; Habeeb, F; Jadaon, MM; Panigrahi, D; West, PW, 2008) |
| "Enteric fever is a major public health problem in India." | 1.35 | An increase in enteric fever cases due to Salmonella Paratyphi A in & around Chandigarh. ( Chander, J; Gupta, V; Kaur, J, 2009) |
| "Nalidixic acid resistance has been used as an indirect evidence of increased minimum inhibitory concentration for ciprofloxacin in Salmonella Typhi." | 1.35 | High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India. ( Kumar, Y; Mani, KR; Sharma, A, 2009) |
| "We describe here a case of Salmonella typhi infection of a sacroiliac joint that was cured with ciprofloxacin therapy for six weeks." | 1.35 | Sacroiliitis caused by Salmonella typhi. ( Ayaz, C; Celen, MK; Geyik, MF; Hosoglu, S; Ulug, M, 2009) |
| "Patients with typhoid fever due to Salmonella enterica serotype Typhi strains for which fluoroquinolones MICs are elevated yet that are classified as susceptible by the current interpretive criteria of the Clinical and Laboratory Standards Institute may not respond adequately to fluoroquinolone therapy." | 1.35 | Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. ( Angulo, FJ; Crump, JA; Gay, K; Hanna, SS; Hoekstra, RM; Hurd, S; Joyce, KW; Kretsinger, K; Luedeman, LJ; Megginson, M; Mintz, ED; Segler, SD; Shiferaw, B; Vugia, DJ, 2008) |
| "Typhoid intestinal perforation is a common complication of typhoid fever in our environment." | 1.35 | Typhoid intestinal disease: 32 perforations in 1 patient. ( Abdur-Rahman, LO; Adeniran, JO; Nasir, AA; Odi, TO; Omotayo, JA, 2008) |
| "Low-level quinolone-resistance in typhoid was high in this small series." | 1.35 | Low-level quinolone-resistance in multi-drug resistant typhoid. ( Khan, MA; Mirza, SH, 2008) |
| "We report here a classical case of Salmonella typhi infection in a rare clinical form of a breast abscess in a non-lactating immuno-compromised female." | 1.34 | Salmonella enterica serotype Typhi from a case of breast abscess. ( Chande, DS; Chaudhry, R; Duggal, N; Duggal, S; Hans, C; Mahajan, RK, 2007) |
| "We present three cases of typhoid fever imported to Poland from India in the beginning of the year 2006 treated in our Zoonosis and Tropical Medicine Department." | 1.34 | [Typhoid fever imported from the tropic in Poland]. ( Borkowski, PK; Olszyńiska-Krowicka, M, 2007) |
| "Typhoid fever is an acute infectious disease caused by Salmonella serotype Typhi, leading to endemic or epidemic outbreaks in tropical/ subtropical countries (especially in India, Southeast Asia, Central and South Africa)." | 1.33 | [A case with fever of unknown origin during treatment for malaria: multi-drug resistant Salmonella typhi infection]. ( Akin, K; Cesur, S; Esen, B; Levent, B; Willke, A; Yavuzdemir, S, 2005) |
| "Ciprofloxacin was the most commonly used antibiotic in our study (23 patients)." | 1.33 | Study of clinical profile and antibiotic response in typhoid fever. ( Chowta, MN; Chowta, NK, 2005) |
| "The diagnosis of typhoid fever was made when blood cultures grew Salmonella typhi." | 1.33 | Multiorgan involvement due to Salmonella typhi: case report. ( Ollé-Goig, JE, 2006) |
| "Typhi strains from patients with typhoid fever seen at our center in 1995 (median MIC 0." | 1.32 | Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. ( Abraham, OC; Jesudason, MV; John, TJ; Mathai, D; Rupali, P; Sivaram, S; Zachariah, A, 2004) |
| "A case of typhoid fever with colestatic hepatitis is described, with diagnosis made by stool culture." | 1.32 | [Complications in typhoid fever: description of an anusual case and its bearing on diagnosis and control]. ( de Ramos, FL, 2004) |
| "The rate of recurrence and ADR in the NFX group was lower than that in the CP group." | 1.30 | [Observation of 212 cases of typhoid fever treated with FQNS]. ( Feng, S; Jiang, S; Wang, X, 1997) |
| "We report on the ongoing epidemic of typhoid fever in Tajikistan that started in 1996." | 1.30 | Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use in an epidemic in Tajikistan. ( Aparin, PG; Heymann, DL; Ivanoff, B; Jones, TC; Kuppens, L; Tarr, PE, 1999) |
| " However, there is a need for further studies to evaluate the tissue accumulation of fluoride and its potential to cause toxic effects." | 1.29 | Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growth. ( Arora, NK; Bhan, MK; Jena, A; Pradhan, KM; Susheela, AK, 1995) |
| "Most of these carriers had typhoid in the preantibiotic era and remain potential sources of disease when they provide meals for others, not uncommonly grandchildren." | 1.29 | A case of recurrent typhoid fever in the United States: importance of the grandmother connection and the use of large restriction fragment pattern analysis of genomic DNA for strain comparison. ( Barth, SS; Gibson, JL; Steingrube, VA; Wallace, RJ; Wright, PW, 1994) |
| "We describe here two cases of typhoid fever produced by two identical strains of Salmonella typhi." | 1.29 | [Enteric fever caused by multiresistant Salmonella typhi: 2 autochthonous cases]. ( Gonzalo, N; Martín, C; Royo, G; Satorres, J; Sevillano, A; Yagüe, A, 1993) |
| "To determine the changing spectrum of typhoid fever, a study was conducted on 240 cases of typhoid fever, admitted over a period of 4 years." | 1.29 | Changing spectrum of typhoid. ( Durrani, AB; Rab, SM, 1996) |
| "Ciprofloxacin thus appears to be a good choice in such cases." | 1.29 | Present status of drug resistance in cases of enteric fever in Rajasthan. ( Agarwal, SK; Maheshwari, VD, 1996) |
| "Multidrug resistant typhoid fever (MDRT) is becoming an alarming public health problem in and around Pondicherry, South India." | 1.28 | Multidrug resistant enteric fever. ( Chandra, R; Nalini, P; Rao, RS; Srinivasan, S, 1992) |
| "An unusual manifestation of a Salmonella typhi infection is presented in a patient with a growth hormone producing tumor." | 1.28 | Case report: recurrent Salmonella typhi chest wall abscess associated with a pituitary macroadenoma. ( Hananel, JI; Hulbert, TV; Larsen, RA, 1992) |
| "He developed non-oliguric acute renal failure that was treated successfully." | 1.28 | Typhoid fever, ciprofloxacin, and renal failure. ( Dodd, K; Mellersh, A; Nelson, CS; Simpson, J; Watson, AR, 1991) |
| "A case of typhoid fever caused by a multiply antibiotic resistant strain of Salmonella typhi is reported." | 1.28 | Septicaemia caused by an imported strain of multiply antibiotic resistant Salmonella typhi successfully treated with ciprofloxacin. ( Bhana, R; Coovadia, Y; Seebaran, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (2.65) | 18.7374 |
| 1990's | 73 (32.30) | 18.2507 |
| 2000's | 71 (31.42) | 29.6817 |
| 2010's | 58 (25.66) | 24.3611 |
| 2020's | 18 (7.96) | 2.80 |
| Authors | Studies |
|---|---|
| Veeraraghavan, B | 2 |
| Pragasam, AK | 2 |
| Ray, P | 2 |
| Kapil, A | 7 |
| Nagaraj, S | 2 |
| Perumal, SPB | 2 |
| Saigal, K | 2 |
| Thomas, M | 3 |
| Gupta, M | 2 |
| Rongsen-Chandola, T | 2 |
| Jinka, DR | 2 |
| Shastri, J | 2 |
| Alexander, AP | 2 |
| Koshy, RM | 2 |
| De, A | 4 |
| Singh, A | 2 |
| Evelyn Ebenezer, S | 1 |
| Dutta, S | 4 |
| Bavdekar, A | 2 |
| More, D | 1 |
| Sanghavi, S | 1 |
| Nayakanti, RR | 1 |
| Jacob, JJ | 2 |
| Amladi, A | 1 |
| Anandan, S | 2 |
| Abirami, BS | 1 |
| Bakthavatchalam, YD | 1 |
| Sethuvel, DPM | 1 |
| John, J | 3 |
| Kang, G | 2 |
| Hoang, KV | 1 |
| Woolard, K | 1 |
| Yang, C | 1 |
| Melander, C | 1 |
| Gunn, JS | 1 |
| Chen, CH | 1 |
| Hsu, YJ | 1 |
| Chen, YC | 1 |
| Cheng, SS | 1 |
| Kuo, KC | 1 |
| Chiu, CH | 2 |
| Song, W | 1 |
| Shan, Q | 1 |
| Qiu, Y | 1 |
| Lin, X | 1 |
| Zhu, C | 1 |
| Zhuo, Z | 1 |
| Wang, C | 1 |
| Tong, J | 1 |
| Li, R | 1 |
| Wan, C | 1 |
| Zhu, Y | 1 |
| Chen, M | 1 |
| Xu, Y | 1 |
| Lin, D | 1 |
| Wu, S | 1 |
| Jia, C | 1 |
| Gao, H | 1 |
| Yang, J | 1 |
| Zhao, S | 1 |
| Zeng, M | 1 |
| Nathania, I | 1 |
| Nainggolan, IM | 1 |
| Yasmon, A | 1 |
| Nusatia, ACM | 1 |
| Tjoa, E | 1 |
| Gunardi, WD | 1 |
| Moehario, LH | 1 |
| Kuehn, R | 3 |
| Stoesser, N | 3 |
| Eyre, D | 3 |
| Darton, TC | 3 |
| Basnyat, B | 6 |
| Parry, CM | 8 |
| Ahmad, M | 1 |
| Shah, N | 1 |
| Siddiqui, MA | 1 |
| Ghani, I | 1 |
| Hussain, W | 1 |
| Niaz, Z | 1 |
| Zaman, G | 1 |
| Khurshaid, U | 1 |
| Mirza, IA | 2 |
| Ng'eno, E | 1 |
| Lind, M | 1 |
| Audi, A | 1 |
| Ouma, A | 1 |
| Oduor, C | 1 |
| Munywoki, PK | 1 |
| Agogo, GO | 1 |
| Odongo, G | 1 |
| Kiplangat, S | 1 |
| Wamola, N | 1 |
| Osita, MP | 1 |
| Mugoh, R | 1 |
| Ochieng, C | 1 |
| Omballa, V | 1 |
| Mogeni, OD | 1 |
| Mikoleit, M | 1 |
| Fields, BS | 1 |
| Montgomery, JM | 2 |
| Gauld, J | 1 |
| Breiman, RF | 3 |
| Juma, B | 1 |
| Hunsperger, E | 1 |
| Widdowson, MA | 1 |
| Bigogo, G | 1 |
| Mintz, ED | 4 |
| Verani, JR | 1 |
| Carey, ME | 1 |
| Dyson, ZA | 2 |
| Ingle, DJ | 1 |
| Amir, A | 1 |
| Aworh, MK | 1 |
| Chattaway, MA | 1 |
| Chew, KL | 1 |
| Crump, JA | 4 |
| Feasey, NA | 2 |
| Howden, BP | 1 |
| Keddy, KH | 4 |
| Maes, M | 1 |
| Van Puyvelde, S | 3 |
| Webb, HE | 1 |
| Afolayan, AO | 1 |
| Andrews, JR | 1 |
| Ashton, PM | 1 |
| Bogoch, II | 1 |
| Clemens, JD | 3 |
| da Silva, KE | 1 |
| de Ligt, J | 1 |
| Diaz Guevara, PL | 1 |
| Dolecek, C | 2 |
| Ehlers, MM | 1 |
| Francois Watkins, L | 1 |
| Garrett, DO | 1 |
| Godbole, G | 1 |
| Gordon, MA | 1 |
| Greenhill, AR | 1 |
| Griffin, C | 1 |
| Hendriksen, RS | 1 |
| Heyderman, RS | 1 |
| Hooda, Y | 1 |
| Hormazabal, JC | 1 |
| Ikhimiukor, OO | 1 |
| Iqbal, J | 1 |
| Jenkins, C | 1 |
| Kanteh, A | 1 |
| Karkey, A | 2 |
| Kariuki, S | 2 |
| Kingsley, RA | 1 |
| Lauer, AC | 1 |
| Levine, MM | 3 |
| Lingegowda, RK | 1 |
| Luby, SP | 1 |
| Mackenzie, GA | 1 |
| Mashe, T | 2 |
| Msefula, C | 1 |
| Mutreja, A | 1 |
| Nagaraj, G | 1 |
| Nair, S | 2 |
| Naseri, TK | 1 |
| Nimarota-Brown, S | 1 |
| Njamkepo, E | 1 |
| Okeke, IN | 1 |
| Pollard, AJ | 4 |
| Qadri, F | 1 |
| Qamar, FN | 1 |
| Rahman, SIA | 1 |
| Rambocus, SD | 1 |
| Rasko, DA | 1 |
| Robins-Browne, R | 1 |
| Rutanga, JP | 1 |
| Saha, SK | 3 |
| Saha, S | 1 |
| Sajib, MSI | 1 |
| Seidman, JC | 1 |
| Shakya, J | 1 |
| Shamanna, V | 1 |
| Shrestha, R | 1 |
| Sia, S | 1 |
| Sikorski, MJ | 1 |
| Smith, AM | 5 |
| Tagg, KA | 1 |
| Tamrakar, D | 1 |
| Tanmoy, AM | 1 |
| Thomas, MS | 1 |
| Thomsen, R | 1 |
| Thomson, NR | 1 |
| Tupua, S | 1 |
| Vaidya, K | 1 |
| Valcanis, M | 1 |
| Weill, FX | 3 |
| Wright, J | 1 |
| Dougan, G | 4 |
| Argimón, S | 1 |
| Keane, JA | 1 |
| Aanensen, DM | 1 |
| Baker, S | 5 |
| Holt, KE | 3 |
| Jansson-Knodell, CL | 1 |
| Shin, A | 1 |
| Rogers, N | 1 |
| Jin, C | 1 |
| Gibani, MM | 1 |
| Pennington, SH | 1 |
| Liu, X | 1 |
| Ardrey, A | 1 |
| Aljayyoussi, G | 1 |
| Moore, M | 1 |
| Angus, B | 2 |
| Biagini, GA | 1 |
| Amicizia, D | 1 |
| Micale, RT | 1 |
| Pennati, BM | 1 |
| Zangrillo, F | 1 |
| Iovine, M | 1 |
| Lecini, E | 1 |
| Marchini, F | 1 |
| Lai, PL | 1 |
| Panatto, D | 1 |
| Ngogo, FA | 1 |
| Joachim, A | 1 |
| Abade, AM | 1 |
| Rumisha, SF | 1 |
| Mizinduko, MM | 1 |
| Majigo, MV | 1 |
| Tack, B | 1 |
| Phoba, MF | 1 |
| Barbé, B | 1 |
| Kalonji, LM | 1 |
| Hardy, L | 1 |
| Ingelbeen, B | 1 |
| Falay, D | 1 |
| Ngonda, D | 1 |
| van der Sande, MAB | 1 |
| Deborggraeve, S | 2 |
| Jacobs, J | 3 |
| Lunguya, O | 1 |
| Habeeb Rasool, K | 1 |
| Hammood Hussein, N | 1 |
| Mahamed Taha, B | 1 |
| Saleem, R | 1 |
| Khan, HM | 1 |
| Usman, M | 1 |
| Khokhar, MI | 1 |
| Rasheed, H | 1 |
| Abbas, M | 1 |
| Khan, RR | 1 |
| Zaman, M | 1 |
| Maqsood, Z | 1 |
| Shin, E | 1 |
| Park, J | 1 |
| Jeong, HJ | 1 |
| Park, AK | 1 |
| Na, K | 1 |
| Lee, H | 1 |
| Chun, JH | 1 |
| Hwang, KJ | 1 |
| Kim, CJ | 1 |
| Kim, J | 1 |
| Esa, H | 1 |
| Norazlah, B | 1 |
| Hameed, AA | 1 |
| Ding, CH | 1 |
| Wahab, AA | 1 |
| Amin, MR | 1 |
| Das, SK | 1 |
| Kabir, A | 1 |
| Islam, MR | 1 |
| Ahmed, SM | 1 |
| Hasan, MJ | 1 |
| Duhil de Bénazé, G | 1 |
| Desselas, E | 1 |
| Houdouin, V | 1 |
| Mariani-Kurkdjian, P | 1 |
| Kheniche, A | 1 |
| Dauger, S | 1 |
| Poncelet, G | 1 |
| Gaschignard, J | 1 |
| Levy, M | 2 |
| Smouse, SL | 2 |
| Tau, NP | 1 |
| Bamford, C | 1 |
| Moodley, VM | 1 |
| Jacobs, C | 1 |
| McCarthy, KM | 1 |
| Lourens, A | 1 |
| Zehra, NM | 1 |
| Irfan, F | 1 |
| Imtiaz, A | 1 |
| Nadeem, S | 1 |
| Hameed, F | 1 |
| Elshayeb, AA | 1 |
| Ahmed, AA | 1 |
| El Siddig, MA | 1 |
| El Hussien, AA | 1 |
| Francisco, M | 1 |
| Costa, SS | 1 |
| Belas, A | 1 |
| Ramos, J | 1 |
| Couto, I | 1 |
| Pomba, C | 1 |
| Viveiros, M | 1 |
| Bandyopadhyay, R | 1 |
| Balaji, V | 1 |
| Yadav, B | 1 |
| Jasmine, S | 1 |
| Sathyendra, S | 1 |
| Rupali, P | 2 |
| Britto, CD | 1 |
| Duchene, S | 1 |
| Carter, MJ | 2 |
| Gurung, M | 1 |
| Kelly, DF | 1 |
| Murdoch, DR | 1 |
| Ansari, I | 2 |
| Thorson, S | 1 |
| Shrestha, S | 1 |
| Adhikari, N | 2 |
| Galgallo, DA | 1 |
| Roka, ZG | 1 |
| Boru, WG | 1 |
| Abill, K | 1 |
| Ransom, J | 1 |
| Cuypers, WL | 1 |
| Wong, V | 2 |
| Klemm, EJ | 1 |
| Mutai, WC | 1 |
| Muigai, AWT | 1 |
| Waiyaki, P | 1 |
| Winarsih, S | 1 |
| Kosasih, T | 1 |
| Putera, MA | 1 |
| Rahmadhiani, N | 1 |
| Poernomo, EL | 1 |
| Runtuk, KS | 1 |
| Oswari, MV | 1 |
| Gudza-Mugabe, M | 1 |
| Tarupiwa, A | 1 |
| Munemo, E | 1 |
| Mtapuri-Zinyowera, S | 1 |
| Sooka, A | 2 |
| Stray-Pedersen, B | 1 |
| Mbanga, J | 1 |
| Dahiya, S | 2 |
| Malik, R | 1 |
| Sharma, P | 1 |
| Sashi, A | 1 |
| Lodha, R | 2 |
| Kabra, SK | 3 |
| Sood, S | 4 |
| Das, BK | 4 |
| Walia, K | 1 |
| Ohri, VC | 1 |
| Lee, CJ | 1 |
| Su, LH | 1 |
| Huang, YC | 1 |
| Hassing, RJ | 3 |
| Goessens, WH | 4 |
| Mevius, DJ | 2 |
| van Pelt, W | 3 |
| Mouton, JW | 1 |
| Verbon, A | 2 |
| van Genderen, PJ | 3 |
| Choudhary, A | 1 |
| Gopalakrishnan, R | 1 |
| Nambi, PS | 1 |
| Ramasubramanian, V | 1 |
| Ghafur, KA | 1 |
| Thirunarayan, MA | 1 |
| Mahajan, RK | 2 |
| Kharbanda, P | 1 |
| Ahuja, S | 1 |
| Omprakash, B | 1 |
| Duggal, N | 2 |
| Hans, C | 2 |
| Gil-Fortuño, M | 1 |
| Yagüe-Muñoz, A | 1 |
| Tirado-Balaguer, MD | 1 |
| Lázaro-Santander, R | 1 |
| Manzanet-Andrés, G | 1 |
| Barrett, FC | 1 |
| Knudsen, JD | 1 |
| Johansen, IS | 1 |
| García, C | 1 |
| Lejon, V | 1 |
| Horna, G | 1 |
| Astocondor, L | 1 |
| Vanhoof, R | 1 |
| Bertrand, S | 1 |
| Stricker, BH | 1 |
| Molhoek, N | 1 |
| Kumar, R | 2 |
| Thompson, CN | 2 |
| Kama, M | 1 |
| Acharya, S | 2 |
| Bera, U | 1 |
| Clemens, J | 1 |
| Dawainavesi, A | 1 |
| Edmunds, WJ | 1 |
| Fox, K | 1 |
| Jenkins, K | 1 |
| Khan, MI | 1 |
| Koroivueta, J | 1 |
| Martin, LB | 2 |
| Nilles, E | 1 |
| Pitzer, VE | 1 |
| Singh, S | 2 |
| Raiwalu, RV | 1 |
| Mulholland, K | 1 |
| Chiou, CS | 1 |
| Lauderdale, TL | 1 |
| Phung, DC | 1 |
| Watanabe, H | 2 |
| Kuo, JC | 1 |
| Wang, PJ | 1 |
| Liu, YY | 1 |
| Liang, SY | 1 |
| Chen, PC | 1 |
| Wielding, S | 1 |
| Scott, G | 1 |
| Nüesch-Inderbinen, M | 1 |
| Abgottspon, H | 1 |
| Sägesser, G | 1 |
| Cernela, N | 1 |
| Stephan, R | 1 |
| Misra, R | 3 |
| Prasad, KN | 3 |
| Amrin, N | 2 |
| Kapoor, P | 1 |
| Ghar, M | 1 |
| McCullagh, D | 1 |
| Dobinson, HC | 1 |
| Darton, T | 1 |
| Campbell, D | 1 |
| Jones, C | 1 |
| Snape, M | 1 |
| Stevens, Z | 1 |
| Plested, E | 1 |
| Voysey, M | 1 |
| Kerridge, S | 1 |
| Mahende, C | 1 |
| Ngasala, B | 1 |
| Lusingu, J | 1 |
| Butichi, A | 1 |
| Lushino, P | 1 |
| Lemnge, M | 1 |
| Mmbando, B | 1 |
| Premji, Z | 1 |
| Al-Emran, HM | 1 |
| Eibach, D | 1 |
| Krumkamp, R | 1 |
| Ali, M | 1 |
| Biggs, HM | 1 |
| Bjerregaard-Andersen, M | 1 |
| Cruz Espinoza, LM | 1 |
| Deerin, J | 1 |
| Dekker, DM | 1 |
| Gassama Sow, A | 1 |
| Hertz, JT | 1 |
| Im, J | 1 |
| Ibrango, S | 1 |
| von Kalckreuth, V | 1 |
| Kabore, LP | 1 |
| Konings, F | 1 |
| Løfberg, SV | 1 |
| Meyer, CG | 1 |
| Olack, B | 1 |
| Pak, GD | 1 |
| Panzner, U | 1 |
| Park, SE | 1 |
| Razafindrabe, JL | 1 |
| Rabezanahary, H | 1 |
| Rakotondrainiarivelo, JP | 1 |
| Rakotozandrindrainy, R | 1 |
| Raminosoa, TM | 1 |
| Schütt-Gerowitt, H | 1 |
| Sampo, E | 1 |
| Soura, AB | 1 |
| Tall, A | 1 |
| Warren, M | 1 |
| Wierzba, TF | 1 |
| May, J | 1 |
| Marks, F | 1 |
| Pham Thanh, D | 1 |
| Dongol, S | 1 |
| Ho Thi, N | 1 |
| Rabaa, MA | 1 |
| Arjyal, A | 1 |
| Tran Vu Thieu, N | 1 |
| Voong Vinh, P | 1 |
| Ha Thanh, T | 1 |
| Pradhan, A | 1 |
| Shrestha, SK | 1 |
| Gajurel, D | 1 |
| Pickard, D | 1 |
| Wolbers, M | 1 |
| Thwaites, GE | 2 |
| Sanhueza Palma, NC | 1 |
| Farías Molina, S | 1 |
| Calzadilla Riveras, J | 1 |
| Hermoso, A | 1 |
| Thakare, R | 1 |
| Chopra, S | 1 |
| Dhole, TN | 1 |
| Gupta, V | 3 |
| Kaur, J | 3 |
| Türoff, A | 1 |
| Vollnberg, H | 1 |
| Kohler, BM | 1 |
| Dashti, AA | 2 |
| Jadaon, MM | 2 |
| Habeeb, F | 1 |
| West, PW | 1 |
| Panigrahi, D | 2 |
| Amyes, SG | 1 |
| Duggal, S | 1 |
| Chande, DS | 1 |
| Chaudhry, R | 1 |
| Dimitrov, T | 1 |
| Albaksami, O | 1 |
| Udo, EE | 1 |
| Albert, MJ | 1 |
| Saharan, G | 1 |
| Gupta, A | 1 |
| Gupta, BK | 1 |
| Sharma, BP | 1 |
| Kochar, DK | 1 |
| Purohit, VP | 1 |
| Kaistha, N | 1 |
| Mustapha, O | 1 |
| Kanj, S | 1 |
| Araj, G | 1 |
| Mroueh, S | 1 |
| Dbeibo, G | 1 |
| Seoud, M | 1 |
| Chander, J | 1 |
| van 't Wout, JW | 1 |
| Jones, JO | 1 |
| Visser, LG | 1 |
| Bijlmer, HA | 1 |
| Veldkamp, PJ | 1 |
| van Dissel, JT | 1 |
| Govender, N | 1 |
| Harish, BN | 3 |
| Menezes, GA | 3 |
| Sarangapani, K | 1 |
| Parija, SC | 2 |
| Kumar, Y | 1 |
| Sharma, A | 2 |
| Mani, KR | 1 |
| Ulug, M | 1 |
| Celen, MK | 1 |
| Geyik, MF | 1 |
| Hosoglu, S | 1 |
| Ayaz, C | 1 |
| Clark, TW | 1 |
| Daneshvar, C | 1 |
| Pareek, M | 1 |
| Perera, N | 1 |
| Stephenson, I | 1 |
| Nath, G | 1 |
| Maurya, P | 1 |
| Suwanpimolkul, G | 1 |
| Nilgate, S | 1 |
| Suankratay, C | 1 |
| Ismail, H | 1 |
| Oliver, S | 1 |
| Kim, DM | 1 |
| Neupane, GP | 1 |
| Jang, SJ | 1 |
| Kim, SH | 1 |
| Lee, BK | 1 |
| Gaborieau, V | 1 |
| Marchou, B | 1 |
| Mohanty, S | 1 |
| Gaind, R | 3 |
| Paglietti, B | 2 |
| Paul, P | 2 |
| Rubino, S | 2 |
| Deb, M | 4 |
| Yagnik, VD | 1 |
| Petit, PL | 1 |
| Kovalenko, AN | 2 |
| Zhdanov, KV | 1 |
| Volzhanin, VM | 1 |
| Shishkin, MK | 1 |
| Tokmakov, VS | 1 |
| Karpov, AV | 1 |
| Murachev, AA | 1 |
| Kondratenok, VA | 1 |
| Bhattacharya, SS | 1 |
| Das, U | 1 |
| Choudhury, BK | 1 |
| Khandeparkar, P | 1 |
| Khan, MA | 3 |
| Hays, JP | 1 |
| Medalla, F | 1 |
| Sjölund-Karlsson, M | 1 |
| Shin, S | 1 |
| Harvey, E | 1 |
| Joyce, K | 1 |
| Theobald, L | 1 |
| Nygren, BN | 1 |
| Pecic, G | 1 |
| Gay, K | 2 |
| Austin, J | 1 |
| Stuart, A | 1 |
| Blanton, E | 1 |
| Whichard, JM | 1 |
| Barzilay, EJ | 1 |
| Raza, A | 1 |
| Sarwar, Y | 1 |
| Ali, A | 1 |
| Jamil, A | 1 |
| Haque, A | 2 |
| Olut, AI | 1 |
| Avcı, M | 1 |
| Ozgenç, O | 1 |
| Altay, T | 1 |
| Coşkuner, SA | 1 |
| Ozsu Caymaz, S | 1 |
| Havuk, A | 1 |
| Acharya, D | 1 |
| Trakulsomboon, S | 1 |
| Madhup, SK | 1 |
| Korbsrisate, S | 1 |
| Ayeni, IV | 1 |
| Calver, G | 1 |
| Haque, SS | 1 |
| Emary, K | 1 |
| Moore, CE | 1 |
| Chanpheaktra, N | 1 |
| An, KP | 1 |
| Chheng, K | 1 |
| Sona, S | 1 |
| Duy, PT | 1 |
| Nga, TV | 1 |
| Wuthiekanun, V | 1 |
| Amornchai, P | 1 |
| Kumar, V | 1 |
| Wijedoru, L | 1 |
| Stoesser, NE | 1 |
| Day, NP | 2 |
| Zaidi, AK | 1 |
| Hasan, R | 1 |
| Bhutta, ZA | 1 |
| Gasem, MH | 1 |
| Keuter, M | 1 |
| Dolmans, WM | 1 |
| Van Der Ven-Jongekrijg, J | 1 |
| Djokomoeljanto, R | 1 |
| Van Der Meer, JW | 1 |
| Asna, SM | 1 |
| Haq, JA | 2 |
| Rahman, MM | 2 |
| Lobzin, IuV | 1 |
| Tankhiwale, SS | 1 |
| Agrawal, G | 1 |
| Jalgaonkar, SV | 1 |
| Marzano, AV | 1 |
| Mercogliano, M | 1 |
| Borghi, A | 1 |
| Facchetti, M | 1 |
| Caputo, R | 1 |
| Ozaras, R | 1 |
| Mert, A | 1 |
| Tahan, V | 1 |
| Uraz, S | 1 |
| Ozaydin, I | 1 |
| Yilmaz, MH | 1 |
| Ozaras, N | 1 |
| Butt, T | 1 |
| Ahmad, RN | 1 |
| Mahmood, A | 1 |
| Zaidi, S | 1 |
| Abraham, OC | 1 |
| Jesudason, MV | 2 |
| John, TJ | 1 |
| Zachariah, A | 1 |
| Sivaram, S | 1 |
| Mathai, D | 2 |
| Pal, NK | 1 |
| Mandal, S | 1 |
| Mandal, MD | 1 |
| Kolyvanos Naumann, U | 1 |
| Kaser, L | 1 |
| Vetter, W | 1 |
| Madhulika, U | 1 |
| Slinger, R | 1 |
| Desjardins, M | 1 |
| McCarthy, AE | 2 |
| Ramotar, K | 1 |
| Jessamine, P | 1 |
| Guibord, C | 1 |
| Toye, B | 1 |
| Datta, V | 1 |
| Sahare, P | 1 |
| Chaturved, P | 1 |
| Panhotra, BR | 1 |
| Saxena, AK | 1 |
| Al-Ghamdi, AM | 1 |
| de Ramos, FL | 1 |
| Karunanayake, L | 2 |
| Atukorala, SD | 1 |
| Pandey, R | 1 |
| Dangal, MM | 1 |
| Karanjit, R | 1 |
| Acharya, A | 1 |
| Morshed, MA | 1 |
| Rahman, MA | 1 |
| Akin, K | 1 |
| Yavuzdemir, S | 1 |
| Cesur, S | 1 |
| Levent, B | 1 |
| Esen, B | 1 |
| Willke, A | 1 |
| Kadhiravan, T | 1 |
| Wig, N | 1 |
| Renuka, K | 2 |
| Misra, A | 1 |
| Chowta, MN | 1 |
| Chowta, NK | 1 |
| Nkemngu, NJ | 1 |
| Asonganyi, ED | 1 |
| Njunda, AL | 1 |
| Krogh, K | 1 |
| Hermansen, NO | 1 |
| Wathne, KO | 1 |
| Walia, M | 1 |
| Mehta, R | 1 |
| Aggarwal, P | 3 |
| Kalaivani, M | 1 |
| Rahman, M | 1 |
| Siddique, AK | 1 |
| Shoma, S | 1 |
| Rashid, H | 1 |
| Salam, MA | 1 |
| Ahmed, QS | 1 |
| Nair, GB | 2 |
| Wilson, G | 1 |
| Prabhu, N | 1 |
| Easow, JM | 1 |
| Mukhopadhyay, C | 1 |
| Threlfall, EJ | 7 |
| Day, M | 2 |
| de Pinna, E | 2 |
| Lewis, H | 1 |
| Lawrence, J | 2 |
| Arya, SC | 1 |
| Agarwal, N | 1 |
| Coulter, JB | 1 |
| Beeching, NJ | 1 |
| Morita, M | 1 |
| Ito, K | 1 |
| Hirose, K | 1 |
| Takahashi, H | 1 |
| Shimuta, K | 1 |
| Terajima, J | 1 |
| Ohnishi, M | 1 |
| Harada, M | 1 |
| Matsuzaki, M | 1 |
| Izumiya, H | 1 |
| Ahmed, D | 1 |
| D'Costa, LT | 1 |
| Alam, K | 1 |
| Hossain, MA | 1 |
| Darmstadt, GL | 1 |
| Baqui, AH | 1 |
| Crook, DW | 1 |
| Islam, MN | 1 |
| Islam, M | 1 |
| Hossain, M | 1 |
| El Arifeen, S | 1 |
| Santosham, M | 1 |
| Black, RE | 1 |
| Murgia, M | 1 |
| Dawar, R | 1 |
| Uzzau, S | 1 |
| Cappuccinelli, P | 1 |
| Kownhar, H | 1 |
| Shankar, EM | 1 |
| Rajan, R | 1 |
| Rao, UA | 1 |
| Chitnis, S | 1 |
| Chitnis, V | 2 |
| Hemvani, N | 2 |
| Chitnis, DS | 1 |
| Szakacs, TA | 1 |
| Khanal, B | 1 |
| Sharma, SK | 1 |
| Bhattacharya, SK | 6 |
| Bhattarai, NR | 1 |
| Kanungo, R | 1 |
| Capoor, MR | 1 |
| Nair, D | 1 |
| Ollé-Goig, JE | 1 |
| Olszyńiska-Krowicka, M | 1 |
| Borkowski, PK | 1 |
| Maskey, AP | 1 |
| Campbell, JI | 1 |
| Farrar, JJ | 1 |
| Zimmerman, MD | 1 |
| Al-Khuwaitir, TS | 1 |
| Al-Zuhair, AA | 1 |
| Al-Ghamdi, AG | 1 |
| Khan, A | 1 |
| Kretsinger, K | 1 |
| Hoekstra, RM | 1 |
| Vugia, DJ | 1 |
| Hurd, S | 1 |
| Segler, SD | 1 |
| Megginson, M | 1 |
| Luedeman, LJ | 1 |
| Shiferaw, B | 1 |
| Hanna, SS | 1 |
| Joyce, KW | 1 |
| Angulo, FJ | 1 |
| Sur, D | 1 |
| Manna, B | 2 |
| Sen, B | 1 |
| Bhattacharya, M | 1 |
| Wain, J | 1 |
| Ochiai, RL | 1 |
| Nasir, AA | 1 |
| Adeniran, JO | 1 |
| Abdur-Rahman, LO | 1 |
| Odi, TO | 1 |
| Omotayo, JA | 1 |
| Jones, J | 1 |
| Mirza, SH | 1 |
| Rowe, B | 3 |
| Ward, LR | 4 |
| Alam, MN | 1 |
| Haq, SA | 1 |
| Das, KK | 1 |
| Baral, PK | 1 |
| Mazid, MN | 1 |
| Siddique, RU | 1 |
| Rahman, KM | 1 |
| Hasan, Z | 1 |
| Dutta, P | 5 |
| Koul, PA | 2 |
| Wani, JI | 2 |
| Wahid, A | 2 |
| Pradhan, KM | 1 |
| Arora, NK | 1 |
| Jena, A | 1 |
| Susheela, AK | 1 |
| Bhan, MK | 1 |
| Leung, D | 1 |
| Venkatesan, P | 1 |
| Boswell, T | 1 |
| Innes, JA | 1 |
| Wood, MJ | 2 |
| Haefeli, WE | 1 |
| Ott, R | 1 |
| Bircher, AJ | 1 |
| Burnens, AP | 1 |
| Gohel, DR | 3 |
| Oza, JJ | 2 |
| Ghosh, I | 1 |
| Daga, MK | 1 |
| Sarin, K | 1 |
| Sarkar, R | 1 |
| Raman, TS | 1 |
| Krishnamurthy, L | 1 |
| Menon, PK | 1 |
| Singh, D | 1 |
| Jayaprakash, DG | 1 |
| Takkar, VP | 1 |
| Khurana, S | 1 |
| Takkar, R | 1 |
| Biswal, N | 1 |
| Mathai, B | 1 |
| Bhatia, BD | 1 |
| Srinivasan, S | 2 |
| Ghosh, JB | 1 |
| Samanta, S | 1 |
| Buch, NA | 1 |
| Hassan, MU | 1 |
| Kakroo, DK | 1 |
| Wright, PW | 1 |
| Wallace, RJ | 1 |
| Steingrube, VA | 1 |
| Gibson, JL | 1 |
| Barth, SS | 1 |
| Müller, HE | 1 |
| Wallace, MR | 1 |
| Yousif, AA | 1 |
| Mahroos, GA | 1 |
| Mapes, T | 1 |
| Hyams, KC | 1 |
| Singh, AK | 1 |
| Saleem, SM | 1 |
| Koul, P | 1 |
| Kudva, GC | 1 |
| Keystone, JS | 1 |
| Kozarsky, PE | 1 |
| Lalitha, MK | 1 |
| Kaur, A | 1 |
| Pulimood, BM | 1 |
| Sheorey, HS | 1 |
| Kaundinya, DV | 1 |
| Hulyalkar, VS | 1 |
| Deshpande, AK | 1 |
| Shah, P | 1 |
| Gathwala, G | 1 |
| Singh, CP | 2 |
| Singh, N | 1 |
| Brar, GK | 2 |
| Lal, G | 2 |
| Kumar, H | 1 |
| Akhtar, S | 1 |
| Ahmad, H | 1 |
| Chakravorty, B | 1 |
| Jain, N | 1 |
| Gupta, B | 1 |
| Rajvanshi, P | 1 |
| Sen, MK | 1 |
| Krishna, A | 1 |
| Yagüe, A | 1 |
| Royo, G | 1 |
| Satorres, J | 1 |
| Gonzalo, N | 1 |
| Martín, C | 1 |
| Sevillano, A | 1 |
| Rasaily, R | 2 |
| Saha, MR | 3 |
| Mitra, U | 4 |
| Bhattacharya, MK | 1 |
| Lahiri, M | 1 |
| Nelwan, RH | 1 |
| Zulkarnain, I | 1 |
| Gunawan, J | 1 |
| Supandiman, I | 1 |
| Yusuf, H | 1 |
| Soedjana, P | 1 |
| Syahroni, A | 1 |
| Bethell, DB | 1 |
| Hien, TT | 1 |
| Phi, LT | 1 |
| Vinh, H | 1 |
| Duong, NM | 1 |
| Len, NV | 1 |
| Chuong, LV | 1 |
| White, NJ | 1 |
| Durrani, AB | 1 |
| Rab, SM | 1 |
| McCarron, B | 1 |
| Love, WC | 1 |
| Maheshwari, VD | 1 |
| Agarwal, SK | 1 |
| Mitchell, DH | 1 |
| Singh, PS | 1 |
| Agalar, C | 1 |
| Usubütün, S | 1 |
| Tütüncü, E | 1 |
| Türkyilmaz, R | 1 |
| Atkins, BL | 1 |
| Gottlieb, T | 1 |
| Chatterjee, MK | 2 |
| Garai, T | 1 |
| Sengupta, M | 1 |
| Murdoch, DA | 1 |
| Banatvaia, N | 1 |
| Bone, A | 1 |
| Shoismatulloev, BI | 1 |
| Banatvala, NA | 1 |
| Jiang, S | 1 |
| Wang, X | 1 |
| Feng, S | 1 |
| Thomsen, LL | 1 |
| Paerregaard, A | 1 |
| Skinner, JA | 1 |
| Smith, HR | 1 |
| Lacey, S | 1 |
| Girgis, NI | 1 |
| Butler, T | 1 |
| Frenck, RW | 1 |
| Sultan, Y | 1 |
| Brown, FM | 1 |
| Tribble, D | 1 |
| Khakhria, R | 1 |
| Dash, NR | 1 |
| Seth, P | 1 |
| Tarr, PE | 1 |
| Kuppens, L | 1 |
| Jones, TC | 1 |
| Ivanoff, B | 1 |
| Aparin, PG | 1 |
| Heymann, DL | 1 |
| Aldrey, JM | 1 |
| Fernández-Rial, A | 1 |
| López-González, FJ | 1 |
| Doval, JC | 1 |
| de la Fuente-Fernández, R | 1 |
| Chitnis, D | 1 |
| Verma, S | 1 |
| Kamath, PS | 1 |
| Jalihal, A | 1 |
| Chakraborty, A | 1 |
| Dragsted, UB | 1 |
| Pedersen, P | 1 |
| Doherty, CP | 1 |
| Cutting, WA | 1 |
| Rodrigues, C | 1 |
| Mehta, A | 1 |
| Andrews, R | 1 |
| Joshi, VR | 1 |
| Datta, S | 1 |
| Roy, K | 1 |
| Basak, M | 1 |
| Skull, SA | 1 |
| Tallis, G | 1 |
| Gouthaman, S | 1 |
| Mathew, M | 1 |
| Sekhar, U | 1 |
| Manjunath, S | 1 |
| Arthur, P | 1 |
| Abraham, G | 1 |
| Prabha Adhikari, MR | 1 |
| Baliga, S | 1 |
| Ciraj, AM | 1 |
| Seema, DS | 1 |
| Bhat, GK | 1 |
| Shivananda, PG | 1 |
| Umasankar, S | 1 |
| Wall, RA | 1 |
| Berger, J | 1 |
| Raghupathi, S | 1 |
| Chandrasekaran, V | 1 |
| Vandepitte, J | 1 |
| Lemmens, P | 1 |
| Bhatia, RS | 1 |
| Gulati, S | 1 |
| Marwaha, RK | 1 |
| Prakash, D | 1 |
| Ayyagari, A | 1 |
| Singhi, S | 1 |
| Kumar, L | 1 |
| Singhi, P | 1 |
| Walia, BN | 1 |
| Karthikeyan, G | 1 |
| Nalini, P | 2 |
| Aggarwal, GK | 1 |
| Kumar, D | 1 |
| Nair, RG | 1 |
| Meher, LK | 1 |
| Tripathy, D | 1 |
| Sing, N | 1 |
| Parsad, D | 1 |
| Chew, SK | 1 |
| Monteiro, EH | 1 |
| Lim, YS | 1 |
| Allen, DM | 1 |
| Uwaydah, AK | 2 |
| al Soub, H | 1 |
| Matar, I | 1 |
| Chandra, R | 1 |
| Rao, RS | 1 |
| Akhtar, MA | 1 |
| Hussain, A | 1 |
| Karamat, KA | 1 |
| Naqi, N | 1 |
| Zubdi, N | 1 |
| Narendranathan, M | 1 |
| Geroge, TP | 1 |
| Hananel, JI | 1 |
| Hulbert, TV | 1 |
| Larsen, RA | 1 |
| Kumar, PD | 1 |
| Sen, S | 1 |
| Goyal, RS | 1 |
| Dev, R | 1 |
| Misra, S | 1 |
| Thapa, BR | 1 |
| Mehta, S | 1 |
| Biswas, AC | 1 |
| Hariram, MR | 1 |
| Nagbhushan, S | 1 |
| Simpson, J | 1 |
| Watson, AR | 1 |
| Mellersh, A | 1 |
| Nelson, CS | 1 |
| Dodd, K | 1 |
| Anand, AC | 1 |
| Kataria, VK | 1 |
| Singh, W | 1 |
| Chatterjee, SK | 1 |
| Dawood, ST | 1 |
| Hroob, A | 1 |
| Coovadia, Y | 1 |
| Seebaran, A | 1 |
| Bhana, R | 1 |
| Pithie, AD | 1 |
| Hudson, SJ | 1 |
| Ingham, HR | 1 |
| Snow, MH | 1 |
| Eykyn, SJ | 1 |
| Williams, H | 1 |
| Mandal, B | 1 |
| Flegg, P | 1 |
| Dunbar, E | 1 |
| Whale, K | 1 |
| Brennand, J | 1 |
| Ferreccio, C | 1 |
| Morris, JG | 1 |
| Valdivieso, C | 1 |
| Prenzel, I | 1 |
| Sotomayor, V | 1 |
| Drusano, GL | 1 |
| Klein, E | 1 |
| Trautmann, M | 1 |
| Hoffmann, HG | 1 |
| Carbon, C | 1 |
| Weber, P | 1 |
| Boussougant, Y | 1 |
| Cerf, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase IIb, Observer-blind, Randomised Controlled Trial to Assess the Immunogenicity and Protective Efficacy of Vi Conjugated (Vi-TCV) and Unconjugated (Vi-PS) Polysaccharide Vaccines in Preventing Typhoid Infection Compared to a Control Vaccine (Meningo[NCT02324751] | Phase 2 | 112 participants (Actual) | Interventional | 2015-09-30 | Completed | ||
| Investigating the Mechanisms and Determinants of Systemic and Mucosal Immunity to Salmonella Typhi and Salmonella Paratyphi A in naïve and Previously Exposed Individuals - A Challenge and Rechallenge Study[NCT02192008] | 125 participants (Actual) | Interventional | 2014-12-31 | Completed | |||
| Comparative Study of Commercially Available Typhoid Point of Care Tests to Benchmark Current and Emerging Tools[NCT04673487] | 2,000 participants (Anticipated) | Observational | 2021-01-31 | Not yet recruiting | |||
| Development of a Human Model of Salmonella Enterica Serovar Paratyphi A Challenge in Healthy Adult Volunteers[NCT02100397] | 80 participants (Anticipated) | Interventional | 2014-03-31 | Completed | |||
| Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine, Phase 1 Trial in Adults at NIH CC[NCT00277147] | Phase 1 | 25 participants | Interventional | 2006-01-09 | Completed | ||
| Azithromycin and Cefixime Combination Versus Azithromycin Alone for the Out-patient Treatment of Clinically Suspected or Confirmed Uncomplicated Typhoid Fever in South Asia; a Randomised Controlled Trial[NCT04349826] | Phase 4 | 1,500 participants (Anticipated) | Interventional | 2021-05-23 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for ciprofloxacin and Typhoid Fever
| Article | Year |
|---|---|
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Salmonella typhi; Travel; | 2023 |
Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Bicarbonates; C | 2019 |
Typhoid fever presenting as acute psychosis in a young adult: case report and literature review of typhoid psychosis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Male; Psychotic Disorders; Salmonella typ | 2021 |
Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacteri | 2018 |
Typhoid fever: case report and literature review.
Topics: Anti-Bacterial Agents; Child; Chile; Ciprofloxacin; Diagnosis, Differential; Humans; Male; Microbial | 2016 |
A case report and review of the literature: ciprofloxacin resistant Salmonella enterica serovar Typhi in India.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; India; Male; Mic | 2008 |
Enteric fever in a UK regional infectious diseases unit: a 10 year retrospective review.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; H | 2010 |
Typhoid spondylodiscitis: the first reported case in Southeast Asia and review of the literature.
Topics: Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Discitis; Drug Therapy, Combination; | 2010 |
[Typhoid fever: facing the challenge of resistant strains].
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance; Drug Resistance, | 2010 |
Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacter | 2007 |
Ciprofloxacin-resistant Salmonella typhi and treatment failure.
Topics: Aged; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Infant; Salmonella typhi; Treatment | 1999 |
An evidence-based review of current guidelines for the public health control of typhoid in Australia: a case for simplification and resource savings.
Topics: Anti-Infective Agents; Australia; Carrier State; Ciprofloxacin; Contact Tracing; England; Evidence-B | 2001 |
Treatment of typhoid fever and infectious diarrhoea with ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Humans; Salmonella Infections; Salmonella typhi; Tim | 1990 |
16 trials available for ciprofloxacin and Typhoid Fever
| Article | Year |
|---|---|
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Female; Humans; Male; Middle | 2019 |
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Female; Humans; Male; Middle | 2019 |
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Female; Humans; Male; Middle | 2019 |
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Female; Humans; Male; Middle | 2019 |
Open Label Randomized Controlled Comparison of Three Alternative Regimes of Ciprofloxacin, Azithromycin and Cefixime for Treatment of Uncomplicated Typhoid Fever in Bangladesh.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cefixime; Ciprofloxacin; Humans; Microbial S | 2021 |
Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Healthy Volunteers; Humans; Male; M | 2015 |
A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Fluoroquinolones; Ga | 2016 |
Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever.
Topics: Adolescent; Adult; Bacteremia; Bone Marrow; Chloramphenicol; Ciprofloxacin; Cytokines; Female; Human | 2003 |
Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Drug Administration Schedule; Drug Re | 1995 |
Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever.
Topics: Bacteriophage Typing; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Humans; Treatment Outc | 1993 |
Short course ciprofloxacin therapy for enteric fever.
Topics: Adult; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Male; Paratyphoid Fever; Recurre | 1993 |
Efficacy of ciprofloxacin and norfloxacin in multidrug resistant enteric fever in adults.
Topics: Adolescent; Adult; Ampicillin Resistance; Chloramphenicol Resistance; Ciprofloxacin; Drug Resistance | 1993 |
A comparative study of short course ciprofloxacin treatment in typhoid and paratyphoid fever.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Paratyphoid | 1995 |
Effects on growth of single short courses of fluoroquinolones.
Topics: Adolescent; Anti-Infective Agents; Body Height; Child; Child, Preschool; Ciprofloxacin; Disease Outb | 1996 |
Comparison of two regimens for ciprofloxacin treatment of enteric infections.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Administration Schedule; Female; Human | 1997 |
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Drug R | 1999 |
Typhoid fever, ciprofloxacin and growth in young children.
Topics: Anti-Infective Agents; Body Height; Child; Child, Preschool; Ciprofloxacin; Follow-Up Studies; Human | 2000 |
A 7-day course of ciprofloxacin for enteric fever.
Topics: Administration, Oral; Adult; Bacteremia; Ciprofloxacin; Drug Administration Schedule; Female; Humans | 1992 |
Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever.
Topics: Administration, Oral; Adolescent; Adult; Ciprofloxacin; Drug Administration Schedule; Female; Humans | 1992 |
196 other studies available for ciprofloxacin and Typhoid Fever
| Article | Year |
|---|---|
Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; | 2021 |
Identification of a Host-Targeted Compound to Control Typhoid Fever.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Humans; Pyrroles; Salmonella; Salmonell | 2022 |
Clinical manifestations and microbiological features between indigenous and imported enteric fever in Taiwan, 2010-2020.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Paratyphoid Fever; Retrospective Studies; Salmonella p | 2022 |
Clinical profiles and antimicrobial resistance patterns of invasive Salmonella infections in children in China.
Topics: Ampicillin; Anti-Bacterial Agents; C-Reactive Protein; Ceftriaxone; Child; Child, Preschool; China; | 2022 |
Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
Topics: Amino Acids; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance | 2022 |
Frequency and Antibiotics Sensitivity Pattern of Culture-Positive Salmonella Typhi in Children.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Chloramphe | 2023 |
Antimicrobial susceptibility pattern and genotypic characterisation of quinolone and ceftriaxone resistant genes among Salmonella typhi from various regions of Pakistan.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Humans; M | 2022 |
Dynamic Incidence of Typhoid Fever over a 10-Year Period (2010-2019) in Kibera, an Urban Informal Settlement in Nairobi, Kenya.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Humans; Incidence; Kenya; Salmonella | 2023 |
Acute Diarrheal Illness.
Topics: Acute Disease; Adolescent; Ciprofloxacin; Colon; Diarrhea; Feces; Female; Heart Rate; Humans; Ileum; | 2020 |
Factors associated with Salmonella infection in patients with gastrointestinal complaints seeking health care at Regional Hospital in Southern Highland of Tanzania.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciproflo | 2020 |
Non-typhoidal Salmonella bloodstream infections in Kisantu, DR Congo: Emergence of O5-negative Salmonella Typhimurium and extensive drug resistance.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Ceftriaxone; Child; Child, Presc | 2020 |
Molecular Detection of
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cefepime; Ciprofloxacin; DNA Gyrase; | 2020 |
Population pharmacokinetics of ciprofloxacin in Pakistani patients suffering from enteric fever.
Topics: Ciprofloxacin; Creatinine; Fluoroquinolones; Humans; Models, Biological; Pakistan; Typhoid Fever | 2021 |
Emerging high-level ciprofloxacin-resistant Salmonella enterica serovar typhi haplotype H58 in travelers returning to the Republic of Korea from India.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Haplotypes; Humans; Indi | 2021 |
Pneumonia with pleural empyema caused by Salmonella Typhi in an immunocompetent child living in a non-endemic country.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drainage; Empyema, Pleural; Female; F | 2018 |
Laboratory-acquired infections of Salmonella enterica serotype Typhi in South Africa: phenotypic and genotypic analysis of isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Genome, | 2017 |
Current Trends of Antimicrobial Susceptibility of Typhoidal Salmonellae Isolated at Tertiary Care Hospital.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; D | 2017 |
Prevalence of current patterns and predictive trends of multidrug-resistant Salmonella Typhi in Sudan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Forec | 2017 |
First report on antimicrobial resistance and molecular characterisation of Salmonella enterica serotype Typhi isolated from human specimens in Luanda, Angola.
Topics: Adolescent; Adult; Aged; Angola; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Ba | 2018 |
Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Dr | 2018 |
Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.
Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacteria | 2018 |
Investigation of a typhoid fever epidemic in Moyale Sub-County, Kenya, 2014-2015.
Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Child; Ciprofloxacin; Comm | 2018 |
Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Cross-Sectional Stud | 2018 |
β-Glucan of Candida albicans Cell Wall Extract Inhibits Salmonella Typhimurium Colonization by Potentiating Cellular Immunity (CD8 + and CD4 + T Cells).
Topics: Animals; beta-Glucans; Candida albicans; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cel | 2019 |
Laboratory characterisation of Salmonella enterica serotype Typhi isolates from Zimbabwe, 2009-2017.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Clinical Laboratory Techniques; D | 2019 |
Current antibiotic use in the treatment of enteric fever in children.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multipl | 2019 |
First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resista | 2013 |
Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Blood; Child; Ciprofloxacin; Drug Resistance, Bacter | 2013 |
Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.
Topics: Ampicillin; Chloramphenicol; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bac | 2013 |
Salmonella enterica serotype Typhi from a case of empyema.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Empyema; Humans; Infant; Male; Salmonella typhi; Typhoid Fever | 2011 |
[Isolation of Salmonella enterica serovar Typhi in a mesenteric adenopathy].
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Humans; Lymph Nodes; Male; Mesentery; Salmo | 2013 |
Cases of typhoid fever in Copenhagen region: a retrospective study of presentation and relapse.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Denmark; Drug Resistance, Bacterial; Female | 2013 |
Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Blood; Child; Child, Preschool; Ciprofloxacin; DN | 2014 |
Salmonella subtypes with increased MICs for azithromycin in travelers returned to The Netherlands.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Se | 2014 |
Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure.
Topics: Adult; Child; Child, Preschool; Ciprofloxacin; Directed Molecular Evolution; DNA Gyrase; DNA Topoiso | 2014 |
Typhoid fever in Fiji: a reversible plague?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Child; Child, Preschoo | 2014 |
Antimicrobial resistance in Salmonella enterica Serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam.
Topics: Anti-Bacterial Agents; Bangladesh; Base Sequence; Carrier Proteins; Ciprofloxacin; Drug Resistance, | 2014 |
Sexually acquired Salmonella Typhi urinary tract infection.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; HIV Seropositivity; Homosexuality, Male; Humans; Male; | 2016 |
Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002-2013) and molecular characterization of quinolone resistant isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Humans; Microbial Sens | 2015 |
Absence of multidrug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolates with intermediate susceptibility to ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial | 2015 |
Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania.
Topics: Acute Disease; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Child; Child, Preschool; Chlorampheni | 2015 |
A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.
Topics: Adolescent; Adult; Africa South of the Sahara; Anti-Bacterial Agents; Child; Child, Preschool; Cipro | 2016 |
Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA Gy | 2016 |
Antimicrobial susceptibility to azithromycin among Salmonella enterica Typhi and Paratyphi A isolates from India.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteremia; Ciprofloxacin; Drug Resistance, Bacterial; Humans; | 2016 |
A need to revise ciprofloxacin breakpoints for Salmonella in human beings.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Test | 2008 |
[Acute myocarditis after visiting Pakistan].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; C-Reactive Protein; Ceftriaxone; | 2008 |
Salmonella enterica Serotype typhi in Kuwait and its reduced susceptibility to ciprofloxacin.
Topics: Adolescent; Anti-Bacterial Agents; Bacteriophage Typing; Ciprofloxacin; DNA Gyrase; Drug Resistance, | 2008 |
Salmonella enterica serotype Typhi from a case of breast abscess.
Topics: Abscess; Adult; Anti-Bacterial Agents; Breast Diseases; Ciprofloxacin; Female; Humans; Salmonella ty | 2007 |
Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Blood; Child, Preschool; | 2009 |
Evaluation of antibiotic sensitivity pattern in cases of enteric fever in north west Rajasthan.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resista | 2008 |
Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Mi | 2009 |
Genital ulceration associated with typhoid fever.
Topics: Adolescent; Anti-Infective Agents; Biopsy; Ciprofloxacin; Female; Genital Diseases, Female; Humans; | 2009 |
An increase in enteric fever cases due to Salmonella Paratyphi A in & around Chandigarh.
Topics: Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Disease Outbreaks; Disk Diffusion Antimicrobi | 2009 |
[What does it mean 'sensitive'? Failing ciprofloxacin in typhus abdominalis].
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bact | 2009 |
Quinolone-resistant Salmonella Typhi in South Africa, 2003-2007.
Topics: Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Genotype; Hum | 2010 |
High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, B | 2009 |
Sacroiliitis caused by Salmonella typhi.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Infectious; Ciprofloxacin; Female; Humans; Radiography; Sac | 2009 |
Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftriaxone; Ciprofloxacin; Cluster Analysis; DNA Gyrase; | 2010 |
Fluoroquinolone-resistant typhoid, South Africa.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gene | 2010 |
In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
Topics: Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans | 2010 |
[A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; | 2010 |
Bacteraemia with pleural effusions complicating typhoid fever caused by high-level ciprofloxacin-resistant Salmonella enterica serotype Typhi.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Ceftriaxone; Child; | 2010 |
Response: A case of massive gastrointestinal haemorrhage (ANZ J. Surg. 2010: 80; 190-1).
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Dose-Response Relationship, Drug; Dr | 2010 |
Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asia, Southeastern; Blood; Ciprofloxacin; DNA Gyrase | 2011 |
[Features of clinic, diagnostics and treatment of typhoid fever in young patients].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Hospitalization; Humans; Ma | 2011 |
Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance | 2011 |
Reemergence of chloramphenicol in typhoid fever in the era of antibiotic resistance.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; | 2010 |
Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Blood; Child; Child, Preschool; Ciproflo | 2012 |
Ciprofloxacin-resistant Salmonella enterica Serotype Typhi, United States, 1999-2008.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; DNA Gyrase; DNA To | 2011 |
Effect of biofilm formation on the excretion of Salmonella enterica serovar Typhi in feces.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacterial Proteins; Bacterial Shedding; Biofilms; Caco-2 C | 2011 |
[Septic arthritis of hip due to Salmonella Typhi in a patient with multiple sclerosis].
Topics: Administration, Oral; Adult; Anti-Infective Agents; Arthritis, Infectious; Bacteremia; Bursitis; Cip | 2012 |
Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Hospit | 2012 |
Ciprofloxacin resistant osteomyelitis following typhoid fever.
Topics: Adult; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Debridement; Drug Resistance, Microbial; | 2012 |
Impact of nitric oxide precursor L-arginine on oxidative stress against typhoid.
Topics: Animals; Arginine; Ciprofloxacin; Lipid Peroxidation; Liver; Malondialdehyde; Mice; Nitric Oxide; Ox | 2012 |
Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin.
Topics: Adult; Age Distribution; Anti-Infective Agents; Azithromycin; Cambodia; Ceftriaxone; Child; Child Mo | 2012 |
Typhoid fever.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Chloramphenicol; Ciprofloxacin; Drug Res | 2003 |
Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh.
Topics: Adult; Bangladesh; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sens | 2003 |
[Combined infection of abdominal typhoid and hepatitis A and E].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Diagnosis, Diffe | 2003 |
An unusually high occurrence of Salmonella enterica serotype paratyphi A in patients with enteric fever.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Test | 2003 |
Cutaneous infection caused by Salmonella typhi.
Topics: Adult; Bacteremia; Biopsy, Needle; Ciprofloxacin; Endemic Diseases; Female; Follow-Up Studies; Human | 2003 |
Ciprofloxacin and Achilles' tendon rupture: a causal relationship.
Topics: Achilles Tendon; Adult; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedul | 2003 |
Ciprofloxacin treatment failure in typhoid fever case, Pakistan.
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Pakistan; Salmonella typhi; Treatmen | 2003 |
Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi.
Topics: Adolescent; Adult; Child; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; | 2004 |
Scattergram analysis to explore the emerging problem related to in vitro susceptibility test for Salmonella enterica serovar Typhi to ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivi | 2004 |
[Typhus abdominalis].
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Dose-Response Relationship, Dr | 2004 |
Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
Topics: Anti-Infective Agents; Bacteriophage Typing; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, | 2004 |
Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Topics: Anti-Infective Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Micr | 2004 |
Guillain-Barre syndrome as a complication of enteric fever.
Topics: Anti-Infective Agents; Child; Ciprofloxacin; Diagnosis, Differential; Female; Guillain-Barre Syndrom | 2004 |
Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Blood Chemical Analysis; Child, Preschool; Ciprofloxacin; | 2004 |
[Complications in typhoid fever: description of an anusual case and its bearing on diagnosis and control].
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Feces; Hepatitis; Humans; Male; Salmonella typhi; | 2004 |
Enteric fever caused by Salmonella isolates with decreased susceptibility to ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Follow-Up Studies; Humans; Microbi | 2004 |
Enteric fever: is ciprofloxacin failing in Nepal?
Topics: Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Drug Resistance, M | 2005 |
Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Ciprofloxacin; Drug Resistance, Bacterial; Hospitals, Urban; Huma | 2005 |
[A case with fever of unknown origin during treatment for malaria: multi-drug resistant Salmonella typhi infection].
Topics: Adult; Afghanistan; Agglutination Tests; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin | 2005 |
Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Child; Child, Preschool; Ciprofloxacin; Drug Res | 2005 |
Study of clinical profile and antibiotic response in typhoid fever.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chlora | 2005 |
Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon.
Topics: Adult; Anti-Bacterial Agents; Cameroon; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacte | 2005 |
[Typhoid and paratyphoid fever in children].
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple | 2005 |
Current perspectives of enteric fever: a hospital-based study from India.
Topics: Adolescent; Adult; Age Distribution; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; | 2005 |
High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Male; Salmon | 2005 |
Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh.
Topics: Anti-Infective Agents; Bangladesh; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple; Huma | 2006 |
Ciprofloxacin-resistant Salmonella enterica serotype typhi in a patient with osteomyelitis of the rib.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Male; | 2005 |
Drug-resistant enteric fever in the UK.
Topics: Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Salmonella | 2006 |
Ciprofloxacin resistance in Salmonella enterica serotype Typhi/Paratyphi and antimicrobial agent quality and bioavailability.
Topics: Anti-Bacterial Agents; Biological Availability; Ciprofloxacin; Humans; Microbial Sensitivity Tests; | 2006 |
Test for quinolone resistance in typhoid fever.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensit | 2006 |
Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Humans; Mutation; Para | 2006 |
Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Blood; Ciprofloxacin; Culture Media; Drug Resistance, Multiple, B | 2006 |
Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Salmonella typ | 2006 |
Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Deoxyribonucleases, Type II Site-Spec | 2006 |
Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; HIV Infections; Humans; | 2007 |
Ciprofloxacin therapy for typhoid fever needs reconsideration.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivi | 2006 |
An all-inclusive vacation.
Topics: Abscess; Aged; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Dominican Republic; Dr | 2007 |
Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern Nepal.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Dru | 2007 |
Multiorgan involvement due to Salmonella typhi: case report.
Topics: Arthritis; Ceftriaxone; Child; Ciprofloxacin; Humans; Male; Osteomyelitis; Salmonella typhi; Typhoid | 2006 |
[Typhoid fever imported from the tropic in Poland].
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; India; Male; Poland; Salmonella typhi; | 2007 |
Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003.
Topics: Anti-Infective Agents; Ciprofloxacin; Developing Countries; Drug Resistance, Bacterial; Fluoroquinol | 2008 |
Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Bacterial; Fe | 2008 |
Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Dr | 2008 |
Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Electrophoresis, | 2008 |
Typhoid intestinal disease: 32 perforations in 1 patient.
Topics: Anti-Infective Agents; Antiprotozoal Agents; Child, Preschool; Ciprofloxacin; Colectomy; Female; Gen | 2008 |
Alternatives to ciprofloxacin use for enteric Fever, United kingdom.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; | 2008 |
Low-level quinolone-resistance in multi-drug resistant typhoid.
Topics: Anti-Infective Agents; Antimalarials; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; M | 2008 |
Ciprofloxacin-resistant Salmonella typhi in the UK.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; | 1995 |
Ciprofloxacin for multiresistant enteric fever in pregnancy.
Topics: Adult; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Humans; India; | 1995 |
Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growth.
Topics: Adolescent; Body Fluids; Body Height; Cartilage, Articular; Child; Child, Preschool; Ciprofloxacin; | 1995 |
Treatment of typhoid in pregnancy.
Topics: Adolescent; Adult; Asia, Western; Child; Ciprofloxacin; Drug Resistance, Multiple; Female; Humans; M | 1995 |
Hair loss following typhoid fever: a forgotten phenomenon.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Ciprofloxacin; Female; Follow-Up Studies; Humans; Male; Mi | 1995 |
More thoughts on enteric fever.
Topics: Adult; Aged; Carrier State; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Sch | 1994 |
A study of culture positive multidrug resistant enteric fever--changing pattern and emerging resistance to ciprofloxacin.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Humans; Prospective Studies; Typhoid Fever | 1994 |
Clinical profile and therapy in enteric fever.
Topics: Cephalexin; Child, Preschool; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Infant; | 1994 |
Comparison of ciprofloxacin versus cephelexin and gentamicin in the treatment of multi-drug resistant typhoid fever.
Topics: Cephaloridine; Ciprofloxacin; Drug Resistance, Multiple; Gentamicins; Humans; Infant; Infant, Newbor | 1994 |
Use of ciprofloxacin and its resistance in typhoid fever.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Humans; India; Salmonella typhi; Typhoid Fever | 1994 |
Venous thrombosis in enteric fever.
Topics: Child; Ciprofloxacin; Dopamine; Female; Humans; Salmonella typhi; Thrombophlebitis; Typhoid Fever | 1994 |
Enteric fever--a changing sensitivity pattern, clinical profile and outcome.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Chloram | 1994 |
A case of recurrent typhoid fever in the United States: importance of the grandmother connection and the use of large restriction fragment pattern analysis of genomic DNA for strain comparison.
Topics: Aged; Carrier State; Child; Ciprofloxacin; Disease Transmission, Infectious; DNA, Bacterial; Electro | 1994 |
[The high risk of cancer as a motive for treatment of typhoid and paratyphoid carriers].
Topics: Adult; Aged; Bile Duct Neoplasms; Carrier State; Ciprofloxacin; Communicable Disease Control; Female | 1994 |
Changing trends in the treatment of enteric fever.
Topics: Ampicillin; Carrier State; Chloramphenicol Resistance; Ciprofloxacin; Humans; Salmonella typhi; Typh | 1993 |
Chloramphenicol resistant enteric fever complicated by disseminated intravascular coagulation and sensitive to ciprofloxacin.
Topics: Adult; Chloramphenicol Resistance; Ciprofloxacin; Disseminated Intravascular Coagulation; Epistaxis; | 1993 |
Multi drug resistant Salmonella typhi in Bombay.
Topics: Adolescent; Adult; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Micro | 1993 |
Pulmonary manifestations of multidrug-resistant typhoid fever.
Topics: Adolescent; Adult; Child; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; India; Lung Dis | 1993 |
Clinical profile and outcome in enteric fever.
Topics: Adult; Age Factors; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Humans; Salm | 1993 |
Ciprofloxacin-induced catatonia.
Topics: Adult; Catatonia; Ciprofloxacin; Humans; Male; Typhoid Fever | 1993 |
Chloramphenicol resistant enteric fever.
Topics: Adolescent; Adult; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Female; Gentamicins; | 1993 |
[Enteric fever caused by multiresistant Salmonella typhi: 2 autochthonous cases].
Topics: Adult; Bacteriophage Typing; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Salmon | 1993 |
Ciprofloxacin for treatment of severe typhoid fever in children.
Topics: Body Temperature; Carrier State; Child; Child, Preschool; Ciprofloxacin; Critical Illness; Humans; I | 1993 |
Changing spectrum of typhoid.
Topics: Adolescent; Adult; Anti-Infective Agents; Bone Marrow Examination; Ceftriaxone; Cephalosporins; Chil | 1996 |
Acalculous nontyphoidal salmonellal cholecystitis requiring surgical intervention despite ciprofloxacin therapy: report of three cases.
Topics: Adult; Aged; Anti-Infective Agents; Cholecystitis; Ciprofloxacin; Female; Humans; Male; Middle Aged; | 1997 |
Present status of drug resistance in cases of enteric fever in Rajasthan.
Topics: Adolescent; Adult; Aminoglycosides; Ampicillin Resistance; Child; Chloramphenicol Resistance; Ciprof | 1996 |
Ciprofloxacin-resistant Salmonella typhi: an emerging problem.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Humans; Salmonella typhi; Typhoid F | 1997 |
Coexistence of enteric fever with malaria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Brain Diseases; Chloroquine; Ciprofloxa | 1995 |
Neuropsychiatric manifestations of salmonella infection.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Neurocognitive Disorders; Suicide; Typhoid Fever | 1995 |
Emerging drug resistance and vaccination for typhoid fever.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Human | 1998 |
Multi-drug resistant typhoid fever with diarrhea.
Topics: Anti-Infective Agents; Anti-Infective Agents, Local; Child; Child, Preschool; Ciprofloxacin; Diarrhe | 1997 |
Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan.
Topics: Anti-Infective Agents; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance | 1998 |
[Observation of 212 cases of typhoid fever treated with FQNS].
Topics: Adult; Anti-Infective Agents; Child; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Recurrence; Typho | 1997 |
Treatment with ciprofloxacin in children with typhoid fever.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Dr | 1998 |
Ciprofloxacin in typhoid fever.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Humans; India; Microbial Sensitivity Tests; Salmonella ty | 1999 |
Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use in an epidemic in Tajikistan.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Humans; Immunization Programs; Publ | 1999 |
Guillain-Barré syndrome as first manifestation of typhoid fever.
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Humans; Immunoglobulins, Intravenous; Middle Aged; Pol | 1999 |
Multidrug-resistant Salmonella typhi in India.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Humans; India; Salmonella typhi; Ty | 1999 |
Differentiation of typhoid fever from fulminant hepatic failure in patients presenting with jaundice and encephalopathy.
Topics: Adult; Aged; Alkaline Phosphatase; Anti-Infective Agents; Aspartate Aminotransferases; Ciprofloxacin | 2000 |
Relapse of multiresistant Salmonella typhi after combined therapy with ciprofloxacin and ceftriaxone.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Drug Resistance, Microbial | 2000 |
Clinical resistance to ciprofloxacin in Salmonella typhi.
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multi | 1998 |
Ciprofloxacin susceptible Salmonella typhi with treatment failure.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Res | 2001 |
Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Humans; | 2001 |
Diagnostic dilemma in coinfection.
Topics: Adolescent; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Entamoebiasis; Female | 2001 |
Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime.
Topics: Adolescent; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multi | 2002 |
Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Test | 2001 |
A case of ciprofloxacin-resistant typhoid fever.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Feces; Humans; Infant; Male; Microbial Sensitivity Tests; | 1992 |
Widespread occurrence of multiple drug-resistant Salmonella typhi in India.
Topics: Ampicillin Resistance; Bacteriophage Typing; Chloramphenicol Resistance; Ciprofloxacin; Drug Resista | 1992 |
Typhoid fever, not responding to ciprofloxacin therapy.
Topics: Adolescent; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Salmonella t | 1992 |
Multi-drug-resistant Salmonella typhi--a need for therapeutic reappraisal.
Topics: Cefotaxime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Female; | 1992 |
Typhoid fever and nephrotic syndrome--an unusual association.
Topics: Child; Ciprofloxacin; Humans; Male; Nephrotic Syndrome; Typhoid Fever | 1992 |
Ciprofloxacin dose in enteric fever.
Topics: Chloramphenicol Resistance; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Infusions, Intr | 1992 |
Is ciprofloxacin a panacea or do we need a 'use-restricted' drug?
Topics: Ciprofloxacin; Drug Utilization; Humans; India; Microbial Sensitivity Tests; Typhoid Fever | 1992 |
Ciprofloxacin induced psychosis.
Topics: Administration, Oral; Adult; Chloramphenicol Resistance; Ciprofloxacin; Female; Humans; Psychoses, S | 1992 |
Therapy of enteric fever.
Topics: Chloramphenicol Resistance; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Humans; India; | 1992 |
Multidrug resistant enteric fever.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Humans; I | 1992 |
Role of ciprofloxacin in typhoid fever.
Topics: Adult; Chloramphenicol; Ciprofloxacin; Humans; Middle Aged; Typhoid Fever | 1992 |
Chloramphenicol and ciprofloxacin in enteric fever--cost-effectiveness.
Topics: Adult; Chloramphenicol; Ciprofloxacin; Cost-Benefit Analysis; Decision Support Techniques; Drug Cost | 1992 |
Case report: recurrent Salmonella typhi chest wall abscess associated with a pituitary macroadenoma.
Topics: Abscess; Adenoma; Adult; Ampicillin; Ciprofloxacin; Hormones; Humans; Male; Microbial Sensitivity Te | 1992 |
Ciprofloxacin for typhoid fever.
Topics: Chloramphenicol; Ciprofloxacin; Developing Countries; Humans; Salmonella typhi; Typhoid Fever | 1991 |
Ciprofloxacin in the management of multiple drug resistant typhoid fever.
Topics: Adolescent; Amoxicillin; Ampicillin; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resis | 1991 |
Treatment of enteric fever--what next?
Topics: Ampicillin; Cefotaxime; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resistance; Ciprof | 1991 |
Ciprofloxacin--is it going to be the drug of first choice in typhoid fever?
Topics: Child; Ciprofloxacin; Humans; Typhoid Fever | 1991 |
Chloramphenicol versus ciprofloxacin in enteric fever.
Topics: Chloramphenicol; Ciprofloxacin; Drug Utilization; Humans; Paratyphoid Fever; Typhoid Fever | 1991 |
Typhoid fever, ciprofloxacin, and renal failure.
Topics: Acute Kidney Injury; Child; Ciprofloxacin; Humans; Kidney; Male; Typhoid Fever | 1991 |
Epidemic multiresistant enteric fever in eastern India.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Drug R | 1990 |
Treatment of multiresistant Salmonella typhi with intravenous ciprofloxacin.
Topics: Ampicillin Resistance; Child; Chloramphenicol Resistance; Ciprofloxacin; Humans; Infusions, Intraven | 1991 |
Septicaemia caused by an imported strain of multiply antibiotic resistant Salmonella typhi successfully treated with ciprofloxacin.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Feces; Humans; India; Male; Middle Aged; Recurrence; Salm | 1990 |
Treatment of Salmonella typhi carrier state with ciprofloxacin.
Topics: Carrier State; Ciprofloxacin; Feces; Female; Humans; Male; Middle Aged; Quinolines; Typhoid Fever | 1985 |
Treatment of multiresistant Salmonella typhi with oral ciprofloxacin.
Topics: Administration, Oral; Adult; Ciprofloxacin; Drug Resistance, Microbial; Humans; Male; Salmonella typ | 1987 |
Ciprofloxacin in enteric fever.
Topics: Adult; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonel | 1987 |
Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers.
Topics: Adult; Carrier State; Ciprofloxacin; Female; Humans; Male; Middle Aged; Typhoid Fever | 1988 |
[Ciprofloxacin in Salmonella infection and abdominal typhoid].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Carrier State; Ciprofloxacin; Female; Humans; Male; | 1986 |
Short-term ciprofloxacin therapy for typhoid fever.
Topics: Adult; Ciprofloxacin; Female; Humans; Male; Middle Aged; Typhoid Fever | 1987 |